Laboratory Services Agreement between Joint Purchasing Corporation and Specialty Laboratories, Inc.

Summary

This agreement is between Specialty Laboratories, Inc. (the laboratory services provider) and Joint Purchasing Corporation (JPC), effective March 1, 1999. Specialty Laboratories will offer laboratory testing services at special pricing to medical providers participating in JPC's group purchasing programs. The agreement outlines pricing, discounts, payment terms, and conditions for service delivery. Participants must sign a separate agreement to access services. The agreement runs through December 31, 2001, with an option to renew for one year. JPC is not responsible for individual participant payments; each participant is billed directly.

EX-10.18A 6 a2032067zex-10_18a.txt EXHIBIT 10.18A EXHIBIT 10.18A CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR CERTAIN REDACTED PROVISIONS OF THIS AGREEMENT. THE REDACTED PROVISIONS ARE IDENTIFIED BY THREE ASTERISKS ENCLOSED BY BRACKETS AND UNDERLINED. THE CONFIDENTIAL PORTION HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. LABORATORY SERVICES AGREEMENT BY AND BETWEEN JOINT PURCHASING CORPORATION AND SPECIALTY LABORATORIES, INC. CONTRACT # 1234 This document, when signed, constitutes an Agreement, herein referred to as "Agreement", between Specialty Laboratories, Inc., a California corporation, herein referred to as "Vendor", located at 2211 Michigan Avenue, Santa Monica, California 90404-3900 and Joint Purchasing Corporation, herein referred to as "JPC", a New York corporation, located at 1865 Broadway, 11th Floor, New York, New York 10023, and shall become effective March 1, 1999. WHEREAS, Vendor is the provider of laboratory testing services, herein referred to as "Services", and desires to offer the Services to medical providers participating in JPC's group purchasing programs, herein referred to as "Participant" or collectively as "Participants"; and WHEREAS, JPC is a provider of group purchasing services to its Participants on a national basis and wishes to offer the Services to its Participants. NOW, THEREFORE, it is mutually agreed by and between JPC and Vendor as follows: AGREEMENT TERM AND RENEWAL The term of the Agreement will be from March 1, 1999 through December 31, 2001 with an option to renew, upon mutual agreement by both parties and 60 days written notice, for an additional twelve (12) months. During the initial term of the Agreement, pricing will remain the same, however, Vendor reserves the right to increase pricing by the [***]* for Medical Services on the [***]*. ELIGIBLE PARTICIPANTS All Participants, irrespective of Class of Trade, are eligible to benefit from this Agreement, but shall be required to adopt and execute a separate Agreement, incorporated herein as "Attachment A", with Vendor delineating the terms and conditions of this Agreement. DISCOUNTS In accordance with this Agreement, special pricing will be available for selected tests currently offered by Vendor, incorporated herein as "Attachment B". Additionally, a [***]* reduction in standard list price, as published in the Price List current at the time the testing is ordered, will be granted for all tests not listed in Attachment B. However, tests that are unique to Vendor such as chromosome studies, PCR tests, tumor tests, leukemia/lymphomas, etc., incorporated herein as "Exception List - Attachment C", are not included in the [***]* reduction in standard list price. Further, the [***]* reduction in standard - ------------------------------ * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. list price does not apply to any tests that are referred out and any new tests introduced by Vendor after the effective date of this Agreement. The continuance of all discounts and special prices is contingent upon the adherence to the payment terms stated within this Agreement. If such payment terms are not adhered to, all discounts may be discontinued and laboratory service charges shall be recalculated based upon standard list fees current at that time. Discounting may be revoked effective the date at which payment becomes delinquent. In order to maintain compliance with current California regulations, Vendor is required to charge Participants for all testing referred to another laboratory at the price charged to Vendor (subject to change without notice). Vendor charges an additional processing fee for each test to cover the clerical and administrative costs of preparing the specimen(s) for transport. In the event a test currently being performed by Vendor is subsequently referred to another laboratory, Vendor will be required to charge the price charged to Vendor (subject to change without notice). Vendor will make every effort to notify Participants with (30) days notice of any such changes. Participants shall report any discounts they receive to the Medicare and Medicaid programs in accordance with the provisions of 42CFR Section 1001.952(h). PARTICIPANT SPECIFIC PRICING In addition to the pricing detailed in the paragraph of this Agreement entitled DISCOUNTS, Vendor will consider, on a case-by-case basis, discretionary pricing for Participants. This would include a maximum number of [***]* tests that are not part of Attachment B. In order to establish comparative clinical data, Vendor will provide, at no charge, testing on samples previously assayed by a different reference laboratory. This comparative testing is limited to no more than five (5) tests, and not more than 5 samples per test. ASSIGNMENT This Agreement may not be transferred to a successor owner without the expressed written consent of Vendor and JPC. LICENSURE AND ACCREDITATION Vendor is a duly licensed independent clinical laboratory and fully accredited by the College of American Pathologists and CLIA among other certifying agencies. Vendor agrees to maintain appropriate licensure and accreditation during term of this Agreement. AVAILABLE SERVICES In accordance with the letter dated January 27, 1999 from Gary W. Nay, incorporated herein as "Attachment D", Vendor agrees to make Services available to Participants in quantities necessary to meet the consumption requirements of Participants. In the event Vendor is unable to provide the Services requested by Participants, for reasons outside of Vendor's control, - ------------------------------ * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Vendor will contact Participants to determine acceptable alternatives. At the request of Participants, Vendor will either procure a substitute in-house assay or refer the sample to another reference laboratory for testing. In the event testing is referred to another reference laboratory, Participants will be charged Vendor's cost without any additional shipping, handling or administrative charges. SUPPLIES Vendor shall provide to Participants the necessary supplies for the proper preparation and submission of specimens to Vendor. COURIERS AND LOGISTICS Vendor will provide all courier and logistics services required to adequately address the laboratory testing submitted by Participants. CREDIT APPROVAL The offer contained within this Agreement shall be valid contingent upon credit approval from Vendor for each Participant. INVOICE Vendor will bill each Participant on a monthly basis for its reference testing services. All bills will be submitted net of applicable discounts. Each Participant shall be responsible for any and all taxes (city, state, etc.) arising as a result of this Agreement. JPC will not be responsible or liable for the payment of individual Participant invoices. PAYMENT TERMS All bills are due and payable within thirty (30) days from date of invoice. THIRD PARTY BILLING POLICIES Vendor will bill patients and patients' insurance directly provided all the necessary billing information is supplied by the Participant within sixty (60) days of the invoice date, otherwise, Participants are responsible for payment of the total invoice. In the event Participants do not furnish Vendor with all of the information required for either patient, third party, Medicare, Medi-Cal or Medicaid billing within 60 days of the invoice date, Vendor shall not be responsible and/or obligated to bill patient, third party, Medicare, Medi-Cal, or Medicaid on behalf of Participants. In such instance, Participants shall be responsible for the entire balance of the invoice. In cases where Vendor has billed a third party at the request of a participant, and a denial is received due to the lack of provider contractual status or patient ineligibility, Vendor will bill the patient for the services rendered. However, should the third party be a payor prohibiting patient billing, i.e., HMO, Medicare, Medi-Cal or Medicaid carrier, Vendor will bill such denied charges to Participants and will expect payment in full. UTILIZATION REPORTS Vendor agrees to provide JPC with quarterly reports reflecting participant utilization. The reports will include test(s) performed (code and description), volumes and gross sales amounts. The reports will be submitted to JPC in Microsoft Excel 97 & 5.0/95 Workbook format on floppy diskette or Compact Disc no later than thirty (30) days after the end of each quarter. CONTRACT ADMINISTRATION FEE Vendor agrees to pay JPC a quarterly Contract Administration Fee, herein referred to "CAF", for an amount equal to [***]* of the [***]* contracted dollar amount (less any billing adjustments) for each Participant. The checks will be made payable to "Joint Purchasing Corporation" with the initial payment due after the close of June 1999. The CAF is intended to defray the expenses of administering the JPC group purchasing program and marketing programs related to Vendor's services. TERMINATION PROVISIONS JPC and Vendor may terminate the Agreement, without cause, with thirty (30) days written notice. Upon termination of this Agreement, for any reason, the parties agree that Vendor shall continue to pay JPC the CAF as provided herein for the duration of any payment obligations to Vendor by Participants under this Agreement. INDEMNIFICATION Vendor shall indemnify and hold harmless JPC, its Director, officers, employees, agents from any claims, actions, suits or proceedings and all costs related thereto which JPC may suffer on account of actions on the part of the Vendor in providing and rendering the Services under this Agreement, including without limitations, claims relating to patent infringement. JPC shall indemnify and hold harmless Vendor, its Directors, officers, employees and agents from any claims, actions, suits or proceedings and all costs related thereto which the Vendor may suffer on account of actions on the part of JPC in performing its obligations under this Agreement. Vendor represents and warrants to both JPC that upon the effectiveness of the Agreement it will have, and during the term hereof will continue to maintain liability insurance in amounts not less than three million dollars ($3,000,000). Proof of such insurance and the amount thereof shall be provided at the time of execution of this Agreement on behalf of Vendor. The Vendor shall provide JPC with written evidence of such insurance upon written request at any time during the term hereof. FORCE MAJEURE Vendor shall not be liable for any failure to perform its duties under this Agreement due to acts of God; acts, regulations or laws of any government, war or any other condition or cause beyond reasonable control. PRODUCT RECALL AND DISRUPTION OF SERVICES Vendor agrees to provide JPC and Participants notice of any product recall in accordance with any local, state or federal statute or regulation. Should a report or recall of a product be made subsequent to the termination of the Agreement, Vendor shall notify JPC and Participants immediately of such recall or product defect report for Services sold under this Agreement in perpetuity. - ------------------------------ * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Vendor shall notify JPC and Participants in writing prior to any factor which might result in the Vendor's inability to, or disruption of, the availability and delivery of Services. COMPLIANCE POLICIES Participants, Vendor and JPC agree to comply with all applicable regulatory agencies including, but not limited to, CLIA and HCFA. In addition, each party shall administer compliance policies throughout their respective organizations to ensure that such compliance is assured. Examples of such policy topics would include, but not be limited to, patient confidentiality, diagnosis coding, anti-kickback statutes, professional courtesy, and CPT-4 coding. SELF-REFERRAL In the event that Participants have any physician owners, Participants shall notify Vendor of such fact so that the parties can ensure compliance with self-referral restrictions under applicable federal and state law. CHANGE IN RULES AND REGULATIONS In the event that any Medicare or Medicaid law, rule, regulation, policy (or any other federal, state or local law, rule, regulation, policy, or any interpretation thereof) at any time during the term of this Agreement prohibits, restricts or has a materially adverse effect on the Agreement, then the parties to this Agreement shall negotiate in good faith to amend or terminate the Agreement. RECORDS Both parties agree to retain, and make available to the other party upon request, for a period of four (4) years following the furnishing of services under this Agreement itself and all books, documents and records that are necessary to verify the nature and extent of the costs thereof, when requested by the Secretary of Health and Human Services, the Comptroller General of the United States or any of their duly authorized representatives, in a manner that complies with the requirements of Section 1861(v)(1)(I) of the Social Security Act and any regulations promulgated thereto. Both parties agree to notify the other party upon receipt of any such request, related to this Agreement, from any representative of the Secretary of Health and Human Services of the Comptroller General. TEST REQUIREMENTS Vendor represents and warrants that all Services meet the following requirements: A. Services have been approved by CLIA requirements. B. Services are guaranteed not to be misbranded or adulterated. C. Services do not infringe on any United States or foreign patent of any other party. D. Services shall be fit for the use and purpose intended when sold and delivered to Participants. PARTICIPANT PURCHASES Each Participant shall determine on its own whether to purchase the Services. INDEPENDENT CONTRACTOR At all times relevant hereto, Vendor shall function as an independent contractor rendering services to Participants. Vendor shall not be an employee or agent of JPC or Participants and shall not be entitled to any employee benefits from JPC or Participants. ESTIMATED QUANTITIES Neither JPC nor Participants obligate themselves to any estimated volume of purchases of Services. PARTICIPANT ADDITIONS & DELETIONS JPC may at any time and from time to time, add or delete Participants eligible to benefit from the terms of this Agreement. The addition or deletion of a Participant shall have no effect on the terms of this Agreement. CONFIDENTIALITY The terms and conditions of the Agreement are confidential to the parties and may not be disclosed to any third party during the term of the Agreement. GROUP PURCHASING AFFILIATION Vendor reserves the right to offer its Services directly to Participants that have multiple GPO agreements, when directed in writing to do so by Participants, with the proof of said directive supplied to JPC within thirty (30) days of execution. MARKETING ACTIVITIES JPC and the Vendor agree that: A. JPC agrees to allow Vendor the use of JPC's name, logo and other corporate identifiers solely in connection with the offer and sale of Services to Participants under this Agreement, subject to prior approval by JPC. B. JPC agrees to allow Vendor to publicize accomplishments achieved under this Agreement, subject to the prior written approval by JPC. C. JPC agrees to have appropriate personnel accompany Vendor personnel on marketing calls to Participants as reasonably requested by Vendor, subject to prior notice and scheduling conflicts. D. JPC has the right to review and approve Vendor's marketing materials or external communications regarding this Agreement, prior to its release. All releases have to be approved by JPC's Vice President for Contract Operations or his/her designee, prior to any publication. Vendor agrees to participate in the following activities during the term of this Agreement. Intended generally to promote and assist JPC in successfully providing group purchasing services to its Participants, pursuant to this Agreement: A. Vendor agrees to allow JPC the use of Vendor's name, logo and other Vendor corporate identifiers, solely in connection with the offer and sale of Services to participants under this Agreement, subject to prior approval by Vendor. B. Vendor agrees to allow JPC to publicize accomplishments achieved under this Agreement, subject to the prior written approval by Vendor. C. Vendor agrees to have appropriate personnel accompany JPC Sales staff on marketing calls to Participants as reasonably requested by JPC, subject to prior notice and scheduling conflicts. D. Vendor agrees to allow JPC to present its services and programs to Vendor's Sales personnel within thirty (30) days of execution of this Agreement. E. Vendor agrees to allocate time and staff to provide on-going Continuing Education Programs, In-Service Programs, both with Continuous Educational Credits, to all Participants during the term of this Agreement. FAIR LABOR PRACTICES Vendor agrees that it is, and will remain, in full compliance with Sections 6, 7 and 12 of the Fair Labor Standards Act as set forth under the Civil Rights Act, Executive Order # 11246 throughout the term of this Agreement. GOVERNING LAW This Agreement shall be governed, construed and interpreted in accordance with the laws of the State of New York. VENUE AND INTERPRETATION OF THE LAW Participants agree and specifically acknowledge that all of the services undertaken and/or performed by Vendor are rendered from Santa Monica, Los Angeles County, California. Vendor agrees that if any actions are to brought by either Vendor or Participants relating to this Agreement, that said action, suit or proceeding shall be filed and conducted in the courts of New York in the State of New York. HEADINGS Paragraph captions contained within this Agreement are for convenience only and do not constitute language within this Agreement. ATTORNEY'S FEE/COSTS Vendor and JPC hereby agree that if any action, suit or proceeding is filed by either party to enforce the terms of this Agreement, that the prevailing party is entitled to its actual attorney's fees and costs in initiating and/or prosecuting said action, suit or proceeding. NOTICES Any and all notices required under this Agreement shall be in writing and shall be given by registered/certified mail, return receipt requested, and postage prepaid to the party or parties for whom such notices are intended. All such notices shall be addressed to the appropriate address set forth in the initial paragraph of this Agreement or such other address of which the parties may be notified in writing from time to time during the term hereof. REQUIREMENTS Upon acceptance of this Agreement, Vendor will immediately provide the following materials to JPC: A. Contract contact person and telephone number B. Marketing contact person and telephone number C. Client Service contact person telephone and fax number D. Web site address E. Shipping terms F. Fee Schedule to be submitted on floppy diskette in Microsoft Excel 97 format; prepared for CUSTOMER VIEWING ONLY. To include the following: i. Pricing for all available Services ii. Directory of Services SIGNATURES Each party represents that the undersigned individuals are authorized by, and on behalf of, their respective organizations to enter into a binding contractual relationship by signing this Agreement as of the effective date of this Agreement. FOR: ACCEPTED: SPECIALTY LABORATORIES, INC. JOINT PURCHASING CORPORATION SANTA MONICA, CALIFORNIA NEW YORK, NEW YORK NAME: MICHAEL K. BOND NAME: JOHN VIVENZIO SIGNATURE: /s/ MICHAEL K. BOND SIGNATURE: /s/ JOHN VIVENZIO ---------------------------- -------------------------- TITLE: MANAGER, CONTRACT ADMINISTRATION TITLE: VICE PRESIDENT FOR CONTRACT OPERATIONS -------------------------------- ------------------------------ DATE: 2-25-99 DATE: 2/28/99 --------------------------------- ------------------------------- ATTACHMENT A LABORATORY SERVICES AGREEMENT FOR JOINT PURCHASING CORPORATION PARTICIPANTS This document, when signed, constitutes an agreement between Specialty Laboratories, Inc. ("SPECIALTY") and medical providers participating in the group purchasing program of Joint Purchasing Corporation ("Participant"). In accordance with the Laboratory Services Agreement by and between Specialty Laboratories and Joint Purchasing Corporation, SPECIALTY offers to Participant the terms and conditions agreed upon in said Agreement. Terms and conditions are summarized below. In turn, Participant accepts the terms and conditions applicable to its performance and responsibilities as outlined within said Agreement. Pricing to Participant will be as shown in the attached fee schedule. Additionally, a [***]* reduction in standard list price, as published in the Price List current at the time the testing is ordered, will be granted for all tests not listed in the fee schedule. However, tests that are unique to SPECIALTY, such as chromosome studies, PCR tests, tumor tests, leukemia/lymphomas, etc., are not included in the [***]* reduction in standard list price. Further, the [***]* reduction in standard list price does not apply to any tests that are referred out and any new tests introduced by SPECIALTY after the effective date of this Agreement. This Agreement shall be effective as of acceptance defined herein and shall continue until December 31, 2001. This Agreement may be terminated by either party at any time, at will, and without cause upon not less than thirty (30) days prior written notice to the other party. Beginning effective date shall be the first billing month after agreement is accepted by both parties. The offer contained within this Agreement shall be valid contingent upon credit approval from SPECIALTY. Payment terms are net 30. All bills are due and payable within thirty (30) days from date of invoice. Participant is responsible for all taxes (city, state, etc.) arising as a result of this agreement. The continuance of all discounts and special prices is contingent upon the adherence to the payment terms. If such payment terms are not adhered to, all discounts may be discontinued and laboratory service charges shall be recalculated based upon standard list fees current at that time. Discounting may be revoked effective the date at which payment becomes delinquent. In order to maintain compliance with current California regulations, SPECIALTY is required to charge Participant for all testing referred to another laboratory at the price charged to SPECIALTY (subject to change without notice). SPECIALTY charges an additional processing fee for each test to cover the clerical and administrative costs of preparing the specimen(s) for transport. - ------------------------ * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. - ------------------------------------------------------------------------------- Laboratory Services Agreement Specialty Laboratories, Inc. JPC Participant Page 1 of 4 ATTACHMENT A In the event a test currently being performed by SPECIALTY is subsequently referred to another laboratory, SPECIALTY will be required to charge the price charged to SPECIALTY (subject to change without notice). SPECIALTY will make every effort to notify Participant with (30) days notice of any such changes. Participant shall report any discounts they receive to the Medicare and Medicaid programs in accordance with the provisions of 42 CFR Section 1001.952(h). SPECIALTY shall not be liable for any failure to perform its duties under this agreement due to acts of God; acts, regulations or laws of any government; war or any other condition or cause beyond reasonable control. This agreement shall be governed and construed in accordance with the laws of the State of California. This Agreement may not be transferred to a successor owner without the expressed written consent of SPECIALTY. Each party agrees to mutually indemnify and hold harmless, their directors, officers, employees, and agents from and against any and all claims, actions, or liabilities of any nature which may be assessed against them by third parties in connection with the performance of services under this agreement. SPECIALTY shall provide to Participant the necessary supplies for the proper preparation and submission of specimens to SPECIALTY. SPECIALTY will provide all courier and logistics services required to adequately address the laboratory testing submitted by Participant. SPECIALTY will bill patients and patients' insurance directly provided all the necessary billing information is supplied by the Participant within sixty (60) days of the invoice date, otherwise, Participant is responsible for payment of the total invoice. In the event Participant does not furnish SPECIALTY with all of the information required for either patient, third party, Medicare, Medi-Cal or Medicaid billing within 60 days of the invoice date, SPECIALTY shall not be responsible and/or obligated to bill patient, third party, Medicare, Medi-Cal, or Medicaid on behalf of Participant. In such instance, Participant shall be responsible for the entire balance of the invoice. In cases where SPECIALTY has billed a third party at the request of a Participant, and a denial is received due to the lack of provider contractual status or patient ineligibility, SPECIALTY will bill the patient for the services rendered. However, should the third party be a payor prohibiting patient billing, i.e. HMO, Medicare, Medi-Cal or Medicaid carrier, SPECIALTY will bill such denied charges to Participant and will expect payment in full. Participant agree to comply with all applicable regulatory agencies including, but not limited to, CLIA and HCFA. In addition, each party shall administer compliance policies throughout their respective organizations to ensure that such compliance is assured. Examples of such policy - ------------------------------------------------------------------------------- Laboratory Services Agreement Specialty Laboratories, Inc. JPC Participant Page 2 of 4 ATTACHMENT A topics would include, but not be limited to, patient confidentiality, diagnosis coding, anti-kickback statutes, professional courtesy, and CPT-4 coding. In the event that Participant has any physician owners, Participant shall notify SPECIALTY of such fact so that the parties can ensure compliance with self-referral restrictions under applicable federal and state law. In the event that any Medicare or Medicaid law, rule, regulation, policy (or any other federal, state or local law, rule, regulation, policy, or any interpretation thereof) at any time during the term of this Agreement prohibits, restricts or has a materially adverse effect on the Agreement, then the parties to this Agreement shall negotiate in good faith to amend or terminate the Agreement. Both parties agree to retain, and make available to the other party upon request, for a period of four (4) years following the furnishing of services under this Agreement itself and all books, documents and records that are necessary to verify the nature and extent of the costs thereof, when requested by the Secretary of Health and Human Services, the Comptroller General of the United States or any of their duly authorized representatives, in a manner that complies with the requirements of Section 1861(v)(1)(I) of the Social Security Act and any regulations promulgated thereto. Both parties agree to notify the other party upon receipt of any such request, related to this Agreement, from any representative of the Secretary of Health and Human Services or the Comptroller General. At all times relevant hereto, SPECIALTY shall function as an independent contractor rendering services to Participant. SPECIALTY shall not be an employee or agent of Participant and shall not be entitled to any employee benefits from Participant. SPECIALTY and Participant hereby agree that if any action, suit or proceeding is filed by either party to enforce the terms of this Agreement, that the prevailing party is entitled to its actual attorney's fees and costs in initiating and/or prosecuting said action, suit or proceeding. The terms and conditions of the Agreement are confidential to the parties and may not be disclosed to any third party during the term of the Agreement. - ------------------------------------------------------------------------------- Laboratory Services Agreement Specialty Laboratories, Inc. JPC Participant Page 3 of 4 ATTACHMENT A FOR: ACCEPTED: SPECIALTY LABORATORIES, INC. JPC PARTICIPANT SANTA MONICA, CALIFORNIA NAME: Michael K. Bond NAME: ---------------------------------- -------------------------------- SIGNATURE: SIGNATURE: ----------------------------- --------------------------- TITLE: Manager, Contract Administration TITLE: -------------------------------- ------------------------------- DATE: DATE: ---------------------------------- -------------------------------- ------------------------------------- Participant Name ------------------------------------- Participant Address ------------------------------------- City, State, Zip ------------------------------------- Specialty Account Number(s), if available Please mail or fax this signature page to: Specialty Laboratories, Inc. Attention: Contract Administration 2211 Michigan Avenue Santa Monica, CA 90404-3900 Fax: (310) 828-1492 - ------------------------------------------------------------------------------- Laboratory Services Agreement Specialty Laboratories, Inc. JPC Participant Page 4 of 4 ATTACHMENT B SPECIALTY LABORATORIES JOINT PURCHASING CORPORATION

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 5 2161C Babesia microti IgG & IgM Abs CSF [***]* 2161P Babesia microti IgG & IgM Abs Paired [***]* 2136 Babesia microti IgG Abs [***]* 2136P Babesia microti IgG Abs Paired [***]* 2141 Babesia microti IgM Abs [***]* 2141P Babesia microti IgM Abs Paired [***]* 2146 Babesia spp. Organism Detection [***]* 2151 Babesiosis Evaluation [***]* 9601 Bacterial Ag Detection [***]* 9601C Bacterial Ag Detection CSF [***]* 9601U Bacterial Ag Detection Urine [***]* 4072 Bacterial Permeability-increasing (BPI) Protein Autoabs Eval [***]* 4108U Barbiturates Urine [***]* 8861 Bartonella henselae & B. quintana DNA DetectR [***]* 8863 Bartonella henselae & B. quintana IgG & IgM Abs SeroDx [***]* 8857 BartonelIa henselae CNS Infection Evaluation [***]* 8851 Bartonella henselae IgG & IgM Abs [default] [***]* 8851C Bartonella henselae IgG & IgM Abs CSF [***]* 8851P Bartonella henselae IgG & IgM Abs Paired [***]* 8855 Bartonella henselae IgG & IgM Antibody Index [***]* 7511 Bartonella quintana DNA DetectR [***]* 8864 Bartonella quintana IgG & IgM Abs [***]* 2413 Bartonella spp. Culture [***]* 1888 bcl-2-Gene Translocation [SB] [***]* 1890 bcr/abl Gene Rearrangement [SB] [***]* 5350 bcr/abl Gene Translocation [PCR] [***]* 1588U Bence-Jones Protein, Qualitative Urine [***]* 4110 Benzodiazepine Screen Serum [***]* 4110U Benzodiazepine Screen Urine [***]* 4073 Benztropine [cogentin] [***]* 1470 Beryllium-induced Lymphocyte Proliferation [***]* 1472 Beryllium-specific in vitro Immunization System [***]* 1083 Beta-2-Glycoprotein I IgG, IgM & IgA Autoabs [Beta-2-GPI] [***]* 3143 Beta-2-MicrogIobuIin [***]* 3143C Beta-2-Microglobulin CSF [***]* 3143F Beta-2-Microglobulin Fluid [***]* 3143U Beta-2-Microglobulin Urine [***]* 3143SR Beta-2-Microglobulin w/Serial Graphics [***]* 3886 Beta-chemokine Panel [***]* 3323 Beta-Glucuronidase [***]* 3323C Beta-Glucuronidase CSF [***]* 3187 Beta-hCG Pregnancy [***]* 4970 Beta-Thalassemia and Hemoglobinopathy Screen [***]* 5941 Beta-Thromboglobulin [***]* 5300 Bicarbonate [***]* 5313 Bilirubin Fractionated [***]* 3554 Bilirubin, Total [***]* 9617 Bladder Tumor Antigen [***]* 8346 Blastomyces IgG Abs [default] [***]* 8346C Blastomyces IgG Abs CSF [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 6 8346P Blastomyces IgG Abs Paired [***]* 8340 Blastomyces IgG Antibody Index [***]* 2511 Blastomyces Total Abs [CF] [default] [***]* 2511C Blastomyces Total Abs [CF] CSF [***]* 2511P Blastomyces Total Abs [CF] Paired [***]* 2328 Blastomyces Total Abs [DD] [***]* 2328C Blastomyces Total Abs [DD] CSF [***]* 2428 Bordetella pertussis / parapertussis Ag Detection [***]* 2416 Bordetelia pertussis / parapertussis Culture [***]* 2430 Bordetella pertussis / parapertussis Evaluation [***]* 9671 Bordetella pertussis / parapertussis IgG Abs [***]* 9671C Bordetella pertussis / parapertussis IgG Abs CSF [***]* 9671CP Bordetella pertussis / parapertussis IgG Abs CSF Paired [***]* 9671P Bordetella pertussis / parapertussis IgG Abs Paired [***]* 9676 Bordatella pertussis / parapartussis IgG, IgM & IgA Abs [***]* 9676C Bordetella pertussis / parapartussis IgG, IgM & IgA Abs CSF [***]* 9676P Bordetella pertussis / parapertussis IgG, IgM & IgA Abs Pair [***]* 9676CP Bordetella pertussis / parapertussis IgG, IgM &IgA Abs Pr CSF [***]* 9681 Bordetella pertussis / parapertussis IgM & IgA Abs [***]* 9681C Bordetella pertussis / parapertussis IgM & IgA Abs CSF [***]* 9681CIP Bordetelia pertussis / parapertussis IgM & IgA Abs Pair CSF [***]* 9681P Bordetella pertussis / parapertussis IgM & IgA Abs Paired [***]* 9686 Bordetella pertussis / parapertussis IgM Abs [***]* 9687 Bordetella pertussis Toxin IgG Abs [***]* 7570 Borrelia burgdorferi DNA DetectR [***]* 8941 Borrelia burgdorferi IgG & IgM Abs [EIA] [default] [***]* 8941C Borrelia burgdorferi IgG & IgM Abs [EIA] CSF [***]* 8941P BorreIia burgdorferi IgG & IgM Abs [EIA] Paired [***]* 8941CP Borrelia burgdorferi IgG & IgM Abs [EIA] Paired CSF [***]* 8941SF Borrelia burgdarferi IgG & IgM Abs [ElA] Syn Fluid [***]* 7711 Borrelia burgdorferi IgG & IgM Abs [IB] [***]* 7711B Borrelia burgdorferi IgG & IgM Abs [IS] + bands [***]* 7711C Borrelia burgdorferi IgG & IgM Abs [IB] CSF [***]* 7711CB Borrelia burgdorferi IgG & IgM Abs [IB] CSF + bands [***]* 7711BP Borrelia burgdorferi IgG & IgM Abs [lB] Paired + bands [***]* 7711SF Borrelia burgdorferi IgG & IgM Abs [IS] Syn Fluid [***]* 7716 Borrelia burgdorferl IgG & IgM Abs with IB [***]* 7716B Borrelia burgdorferi IgG & IgM Abs with IB + bands [***]* 7716C Borrelia burgdorferi IgG & IgM Abs with IB CSF [***]* 7716C8 Borrelia burgdorferi Igg & IgM Abs with IB CSF + bands [***]* 7716P Borrelia burgdorferi IgG & IgM Abs with IB Paired [***]* 7716BP Borrelia burgdorferi IgG & IgM Abs with IB Paired + bands [***]* 7716SF Borrelia burgdorferi IgG.& IgM Abs with IB Syn Fluid [***]* 7970 Borrelia burgdorferi IgG & IgM Antibody Index [***]* 7970SF Borrelia burgdorferi IgG & IgM Antibody Index Synovial Fluid [***]* 7970SF Borrelia burgdorferi IgG & IgM Antibody Index Synovial Fluid [***]* 8951 Borrelia burgdorferi IgG Abs [***]* 8951C Borrelia burgdarferi IgG Abs CSF [***]* 8951CP Borrelia burgdorferi IgG Abs CSF Paired [***]* 8951P Borrelia burgdorferi IgG Abs Paired [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 7 8951SF Borrelia burgdorferi IgG Abs Syn Fluid [***]* 8945 Borrelia burgdorferi IgG Antibody Index [***]* 8945SF Borrelia burgdorferi IgG Antibody Index Synovial Fluid [***]* 8961 Borrelia burgdorferi IgM Abs [***]* 8961C Borrelia burgdorferi IgM Abs CSF [***]* 8961P Borrelia burgdorferi IgM Abs Paired [***]* 8961CIP Borrelia burgdorferi IgM Abs Paired CSF [***]* 8961SF Borrelia burgdorferi IgM Abs Syn Fluid [***]* 7975 Borrelia burgdorferi IgM Antibody Index [***]* 1646 Borrelia burgdorferi Lymphocyte Proliferation Analysis [***]* 9396 Borrelia hermsii IgG & IgM Abs [***]* 9396C Borrelia herrnsii IgG & IgM Abs CSF [***]* 9396P Borrelia hermsiliIgG & IgM Abs Paired [***]* 9326 Borrelia hermsii IgG Abs [***]* 9331 Borrelia hermsii IgM Abs [***]* 2415 Borrelia spp. Culture [***]* 3022 Breast Cancer Monitor I [***]* 3022SR Breast Cancer Monitor I w/Serial Graphics [***]* 3023 Breast Cancer Monitor II [***]* 3023SR Breast Cancer Monitor II w/Serial Graphics [***]* 1805 Breast Cancer Profile 1 - Frozen [***]* 1804 Breast Cancer Profile 1 - Paraffin [***]* 1803 Breast Cancer Profile 2 - Frozen [***]* 1813 Breast Cancer Profile 2 - Paraffin [***]* 1819 Breast Cancer Profile 3 - Paraffin [***]* 1807 Breast Cancer Profile 4 - Frozen [***]* 1817 Breast Cancer Profile 4 - Paraffin [***]* 1801 Breast Cancer Profile 5 - Frozen [***]* 1812 Breast Cancer Profile 5 - Paraffin [***]* 1811 Breast Cancer Profile 6 - Paraffin [***]* 1816 Breast Cancer Profile 7 - Paraffin [***]* 1809 Breast Cancer Profile 9 - Frozen [***]* 8836 Brucella abortus IgG Abs [***]* 8836C Brucella abortus IgG Abs CSF [***]* 8836P Brucella abortus IgG Abs Paired [***]* 7695 Brucella abortus IgG Antibody lndex [***]* 8831C Brucella abortus IgG, IgM & IgA Abs CSF [***]* 8831P Brucella abortus IgG, IgM & IgA Abs Paired [***]* 8831CP Brucella abortus IgG, IgM & IgA Abs Paired CSF [***]* 8831 Brucella abortus IgG, IgM, & IgA Abs [***]* 1116 Brush Border Total Autoabs [***]* 8241 Burkholderia (Pseudomonas) pseudomallei IgG & IgM Abs [***]* 8241C Burkholderia (Pseudomonas) pseudomallei IgG & IgM Abs CSF [***]* 8241P Burkholderia (Pseudomonas) pseudomallei IgG & IgM Abs Paired [***]* 3121 CA 125 [***]* 3121F CA 125 Fluid [***]* 3121SR CA 125 w/Serial Graphics [***]* 3119 CA 15-3 [***]* 3119SR CA 15-3 w/ Serial Graphics [***]* 3120 CA 19-9 [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 8 3120F CA 19-9 Fluid [***]* 3120SR CA 19-9 w/Serial Graphics [***]* 3134 CA27.29 [***]* 3134SR CA27.29 w/Serial Graphics [***]* 4868U Cadmium 24hr Urine [***]* 4500 Cadmium Exposure Panel - OSHA - 24hr Urine [***]* 4500UR Cadmium Exposure Panel - OSHA - Random Urine [***]* 4501U Cadmium Exposure Panel 24hr Urine [***]* 4502U Cadmium Exposure Panel 24hr Urine - Limited [***]* 4868 Cadmium Serum [***]* 4868W Cadmium Whole Blood [***]* 3126 Calcitonin [***]* 4831 Calcium, Ionized [***]* 4831 Calcium, Ionized [***]* 4836 Calcium, Total [***]* 4836U Calcium, Total 24hr Urine [***]* 4836UR Calcium, Urine Random [***]* 8176 California-La Crosse Encephalitis IgM Abs [***]* 8176C California-La Crosse Encephalitis IgM Abs CSF [***]* 8176P California-La Crosse Encephalitis IgM Abs Paired [***]* 7820 California-La Crosse Encephalitis IgM Antibody lndex [***]* 8926 California-La Crosse Encephalitis Total Abs [***]* 8926C California-La Crosse Encephalitis Total Abs CSF [***]* 8926P California-La Crosse Encephalitis Total Abs Paired [***]* 8926CP California-La Crosse Encephalitis Total Abs Paired CSF [***]* 5881 Campylobacter fetus Total Abs [***]* 8881C Campylobacter fetus Total Abs CSF [***]* 8881P Campylobacter fetus Total Abs Paired [***]* 8886 Campylobacter jejuni Total Abs [CF] [***]* 8886C Campylobacter jejuni Total Abs [CF] CSF [***]* 8886P Campylobacter jejuni Total Abs [CF] Paired [***]* 8866 Campylobacter jejuni Total Abs [ElA] [***]* 8866C Campylobacter jejuni Total Abs [EIA] CSF [***]* 5704 Campylobacter spp. Culture [***]* 9190 Candida Ag Detection [***]* 9190P Candida Ag Detection Paired [***]* 2346 Candida albicans Abs Titer [default] [***]* 2346P Candida albicans Abs Titer Paired [***]* 2344 Candida albicans Evaluation [default] [***]* 2343 Candida albicans EvaIuation without Ag [***]* 4132U Cannabinoids Urine [***]* 4114 Carbamazepine [***]* 4116 Carbamazepine, Free [***]* 4003 Carbohydrate-deficient Glycoprotein Syndrome [***]* 4005 Carbohydrate-deficient Transferrin (CDT) UltraQuant [***]* 4001 Carbohydrate-deficient Transferrin and Genetic D Variants [***]* 3999 Carbohydrate-deficient Transferrin, Qualitative [***]* 3258 Carcinoembryonic Ag [CEA] [***]* 3258F Carcinoembryonic Ag Body Fluid [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 9 3258NY Carcinoembryonic Ag New York [***]* 3258SR Carcinoembryonic Ag w/Serial Graphics [***]* 3258C Carcinoembyronic Ag CSF [***]* 3070 Carcinoid Evaluation [***]* 3374 Cardiolipin IgA Autoabs [***]* 3372 Cardiolipin IgG Autoabs [***]* 3371C Cardiolipin IgG, IgM & IgA Abs CSF [***]* 3371P Cardiolipin IgG. IgM & IgA Abs Paired [***]* 3371 CardioIipin IgG, IgM & IgA Autoabs [default] [***]* 3373 Cardiolipin IgM Autoabs [***]* 5991 Cardiovascular Thrombotic Risk AssessR [***]* 3998 Carotenes, alpha and beta [***]* 3304U Catecholamines, Fractionated 24hr Urine [***]* 3304 Catecholamines, Fractionated Plasma [***]* 1851 Cathepsin D [***]* 5368 CC-CKR5 GenotypR [***]* 1692 CD103 Surface Marker [***]* 1686 CD15/30 Surface Marker [***]* 1687 CID 16/55 Surface Marker [***]* 1688 CD19 Surface Marker [***]* 1683 CD3 Surface Marker [***]* 1689 CD38 Surface Marker [***]* 1684 CD4 Surface Marker [***]* 1690 CD41 Surface Marker [***]* 1691 CD42 Surface Marker [***]* 1685 CD8 Surface Marker [***]* 4007 CDT UltraQuant with reflex to Genetic D Variants [***]* 1076 Celiac Disease Abs Evaluation [***]* 1077 Celiac Disease EvaluatR [***]* 1650 Cellular Immune Dysfunction Evaluation [***]* 1109 Centromere Autoabs [***]* 1516 Ceruloplasmin [***]* 9437 Chlamydia pnsumoniae Abs UltraQuant [***]* 2401 Chlamydia pneumoniae Culture [***]* 2922 Chlamydia pneumoniae DNA DetectR [***]* 8081 Chlamydia pneumoniae IgM Abs [***]* 8081P Chlamydia pneumoniae IgM Abs Paired [***]* 8071 Chlamydia pneumoniae Total & IgM Abs [***]* 8071P Chlamydia pneumoniae Total & IgM Abs Paired [***]* 8076 Chlamydia pneumoniae Total Abs [***]* 8076P Chlamydia pneumoniae Total Abs Paired [***]* 8021 Chlamydia psittaci IgM Abs [***]* 8021P Chlamydia psittaci IgM Abs Paired [***]* 8031 Chlamydia psittaci Total & IgM Abs [default] [***]* 8031P Chlamydia psittaci Total & IgM Abs Paired [***]* 8026 Chlamydia psittaci Total Abs [***]* 8026P Chlamydia psittaci Total Abs Paired [***]* 2631C Chlamydia spp. Abs CSF [***]* 8006 Chlamydia spp. Abs Evaluation [***]* 8006P Chlamydia spp. Abs Evaluation Paired [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 10 2631P Chlamydia spp. Abs Paired [***]* 8011 Chlamydia spp. IgM Abs [***]* 8011P Chlamydia spp. Abs Paired [***]* 8066 Chlamydia spp. Total & IgM Abs [default] [***]* 8066P Chlamydia spp. Total & IgM Abs Paired [***]* 2631 Chlamydia spp. Total Abs [***]* 2521 Chlamydia spp. Total Abs [CF] [***]* 2521C Chlamydia spp. Total Abs [CF] CSF [***]* 2521P Chlamydia spp. TOtal Abs [CF] Paired [***]* 8016 Chlamydia spp. Total Abs [MICRO-IF] [***]* 8016P Chlamydia spp. Total Abs [MICRO-IF] Paired [***]* 2927 Chlamydia trachomatis / Neisseria gonorrhoeae by rRNA [***]* 2440 Chlamydia trachomatis Ag Detection [DFA] [***]* 2420 Chlamydia trachomatis Ag Detection [EIA] [***]* 2400 Chlamydia trachomatis Culture [***]* 2925 Chlamydia trachomatis Detection rRNA [***]* 7437 Chlamydia trechomatis DNA LCR [***]* 9391 Chlamydia trachomatis IgA Abs [***]* 9391C Chlamydia trachomatis IgA Abs CSF [***]* 9391P Chlamydia trachomatis IgA Abs Paired [***]* 9406 Chlamydia trachomatis IgG Abs [EIA] [***]* 9406C Chlamydia trachomatis IgG Abs [EIA] CSF [***]* 9406P Chlamydia trachomatis IgG Abs [EIA] Paired [***]* 9321 Chlamydia trachomatis IgG Abs [IB] [***]* 9401 Chlamydia trachomatis IgG IgM & IgA Abs [***]* 9401P Chlamydia trachomatis IgG IgM & IgA Abs Paired [***]* 9411 Chlamydia trechomatis IgM Abs IElA] [***]* 9411C Chlamydia trachomatis IgM Abs [ElA] CSF [***]* 9411P Chlamydia trachomatis IgM Abs [EIA] Paired [***]* 8046 Chlamydia trachomatis IgM Abs [MICRO-IF] [***]* 8046P Chlamydia trachomatis IgM Abs [MlCRO-IF] Paired [***]* 8036 Chlamydia trachomatis Total & lgM Abs [***]* 8036P Chlamydia trachomatis Total & IgM Abs Paired [***]* 8041 Chlamydia trachomatis Total Abs [***]* 8041P Chlamydia trachomatis Total Abs Paired [***]* 4916 Chlordiazapoxide [Librium] [***]* 5303 Chloride [***]* 3454 Cholesterol Evaluation [***]* 3352 Cholesterol HDL [***]* 3350 Cholesterol, Total [***]* 3952 Chromogranin-A [***]* 5832 Chromosome & FISH for Genetic Disorders EvaIuation [***]* 5822 Chromosome Analysis: Amniotic Fluid [***]* 5834 Chromosome Analysis: bcr/abl Gene Rearrangement by FISH [***]* 5814 Chromosome Analysis: Congenital Disorders, Blood [***]* 5830 Chromosome Analysis: FISH for Genetic Diseases [***]* 5800 Chromosome Analysis: HematologicaI Disorders I [***]* 5810 Chromosome Analysis: Hematological Disorders II [***]* 6806AF Chromosome Analysis: Mosaicism Amniotic Fluid [***]* 5806BM Chromosome Analysls: Mosaicism Bone Man-ow [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 11 5806SK Chromosome Analysis: Mosaicism Skin [***]* 5806W Chromosome Analysis: Mosaicism Whole Blood [***]* 5818 Chromosome Analysis: Products of Conception/Skin Biopsies [***]* 5812 Chromosome Analysis: Trisomy 12 by FISH [***]* 5808 Chromosome Analysis: Trisomy 8 by FISH [***]* 1651 Chronic Fatigue & Immune Dysfunction Syndrome Evaluation [***]* 1652 Chronic Fatigue & Immune Dysfunction Syndrome with NK Cell [***]* 1620 Chronic Granulomatous Disease [***]* 4936 Ciprofloxacin [***]* 4936P Ciprofloxacin Peak & Trough [***]* 1040 Circulating Immune CompIex Detector [***]* 1040F Circulating Immune Complex Detector Fluid [***]* 3970 Citrate [***]* 3970U Citrate, 24hr Urine [***]* 4938 Clofazimine [***]* 4938P Clofazimine Peak & Trough [***]* 4962 Clomipramine [Anafranil] & Dasmethylclomipramine [***]* 4918 Clonazepam [***]* 2411 Clostridium difficile Culture [***]* 7672 Clostridium difficile Culture & Toxin Evaluation [***]* 7691 Clostridium difficile Toxin A Detection [***]* 2412 Clostridium difficile Toxin B Detection [***]* 7670 Clostridium difficile Toxin Evaluation [***]* 4964 Clozapine Plasma [***]* 4118U Cocaine Metabolites Urine [***]* 8321 Coccidioides IgG Abs [***]* 8321C Coccidioides IgG Abs CSF [***]* 8321P Coccidioides IgG Abs Paired [***]* 8321CP Coccidioides IgG Abs Paired CSF [***]* 8891 Coccidioides IgG Antibody Index [***]* 8331 Coccidioides IgG, IgM & IgA Abs [***]* 8331C Coccidioides IgG, IgM & IgA Abs CSF [***]* 8331P Coccidioides IgG, IgM & IgA Abs Paired [***]* 8331CP Coccidioides IgG, IgM & IgA Abs Paired CSF [***]* 8316 Coccidioides IgM Abs [***]* 8316C Coccidioides IgM Abs CSF [***]* 8316P Coccidioides IgM Abs Paired [***]* 8316CP Coccidioides IgM Abs Paired CSF [***]* 2526 Coccidioides Total Abs [CF] [default] [***]* 2526C Coccidloides Total Abs (CF) CSF [***]* 2526P Coccidioides Total Abs [CF] Paired [***]* 2526CP Coccidioides Total Abs [CF] Paired CSF [***]* 2332 Coccidioides Total Abs [DD] [***]* 2332C Coccidioides Total Abs [DD] CSF [***]* 2332P Coccidioides Total Abs [DD] Paired [***]* 9166 Coccidioides Total Abs [LPA] [***]* 9166P Coccidioides Total Abs [LPA] Paired [***]* 2030 Coccidioides Total Abs EvaIuation [default] [***]* 2030P Coccidioides Total Abs Evaluation Paired [***]* 9026 Cold Agglutinins [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 12 1476 Collagen Type I & IV IgG Autoabs [***]* 1477 Collagen Type I IgG Autoabs [***]* 1474 Collagen Type II IgG Autoabs [***]* 1478 Collagen Type I & IV IgG Autoabs [***]* 8636 Colorado Tick Fever Total Abs [***]* 8636P Colorado Tick Fever Total Abs Paired [***]* 3024 Colorectal Cancer Monitor [***]* 3024SR Colorectal Cancer Monitor w/Serial Graphics [***]* 1828BK Colorectal Cancer Prognosis - Block [***]* 5902 Complement Deficiency Detector Evaluation [***]* 1020 Complement Evaluation [***]* 1021 Complement Evaluation Plus CH50 [***]* 1940 Complement Functional Activity: C1 Esterase [***]* 1631 Complement Functional Activity: C1 Esterase lnhibitor [***]* 1942 Complement Functional Activity: C2 [***]* 1944 Complement Functional Activity: C3 [***]* 1946 Complement Functional Activity: C4 [***]* 1948 Complement Functional Activity: C5 [***]* 1950 Compiement Functional Activity: C6 [***]* 1952 Complement Functional Activity: C7 [***]* 1954 Complement Functional Activity: C8 [***]* 1956 Complement Functional Activity: C9 [***]* 1958 Complement Functional Activity: Factor B [***]* 1600F Complement Functional Activity: Total CH50 Body Fluid [***]* 1020F Complement Panel Fluid [***]* 1530 Complement Protein Concentration: C 1 Esterase Inhibitor [***]* 1615 Complement Protein Concentration C1q [***]* 1615F Complement Protein Concentration: C1q Fluid [***]* 1970 Complement Protein Concentration: C1r [***]* 1972 Complement Protein Concentration: C1s [***]* 1605 Complement Protein Concentration: C2 [***]* 1501 Complement Protein Concentration: C3 [default] [***]* 1501F Complement Protein Concentration: C3 Body Fluid [***]* 1504 Complement Protein Concentration: C4 [default] [***]* 1504F Complement Protein Concentration: C4 Fluid [***]* 1610 Complement Protein Concentration: C5 [***]* 1938 Complement Protein Concentration: C5a [***]* 1976 Complement Protein Concentration: C6 [***]* 1978 Complement Protein Concentration- C7 [***]* 1980 Complement Protein Concentration: C8 [***]* 1982 Complement Protein Concentration: C9 [***]* 1511 Complement Protein Concentration: Factor B [***]* 1511R Complement Protein Concentration: Factor B Fluid [***]* 1984 Complement Protein Concentration: Factor H [***]* 1986 Complement Protein Concentration: Factor l [***]* 1988 Complement Protein Concentration: Properdin [***]* 1486 Complement Split Product Concentration: C3a [***]* 1486C Complement Split Product Concentration: C3a CSF [***]* 1968 Complement Split Product Concentration: Factor Bb Fragment [***]* 1998 Complement Split Product Concentration: iC3b [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 13 1992 Complement Split Product Concentration; SC5b-9 Complex [***]* 1992C Complement Split Product Concentration; SC5b-9 Complex CSF [***]* 1960 Complement AH50 Total Functional Activity Alternate Pathway [***]* 1962 Complement Alternate Pathway Function [***]* 1994 Complement: C1r:C1s:C1 Inhibitor CompIex [***]* 1723 Complement: C3 & C4 Nephritic Factors EvaIuation [***]* 1612 Complement: C3 Nephritic Factor [***]* 1996 Complement: C3b:Bb:Properdin Complex [***]* 1365 Complement: C4 Allotyping [***]* 1995 Complement C4 Binding Protein [***]* 1721 Complement C4 Nephritic Factor [***]* 1990 Complement Cd/C4 Ratio [***]* 1600 Complement CH50 Total Functional Activity, Classic Pathway [***]* 5111 Complete Blood Count & Differential [***]* 5110 Complete Blood Count, Platelet Count & Differential [***]* 3265 Congenital Adrenal Hyperplasia Evaluation [***]* 1402 Conglutinin Solid Phase Immune Complex Assay [***]* 1402F Conglutinin Solid Phase Immune Complex Assay Fluid [***]* 4870U Copper 24hr Urine [***]* 4870PL Copper Plasma [***]* 4870R Copper RBC [***]* 4870 Copper Serum [***]* 3128 Cortisol [***]* 3136 Cortisol Plasma [***]* 3128C Cortisol, Free 24hr Urine [***]* 2407 Corynebacterium diphtheriae Culture [***]* 9371 Coxiella burnetii IgG Abs, Phase 1 & 2 [***]* 9371C Coxiella bumetii IgG Abs, Phase 1 & 2 CSF [***]* 9381 Coxiella burnetii IgG, IgM, & IgA Abs. Phase 1 & 2 [default) [***]* 9381C Coxiella burnetii IgG. IgM, & IgA Abs. Phase 1 & 2 CSF [***]* 9381P Coxiella burnetii IgG, IgM, & IgA Abs, Phase 1 & 2 Paired [***]* 9376 Coxiella burnetii IgM Abs, Phase 1 & 2 [***]* 93760 Coxiella burnetii IgM Abs, Phase 1 & 2 CSF [***]* 9376P Coxiella burnetii lgM Abs, Phase 1 & 2 Paired [***]* 9371P Coxiella burnetii IgG Abs, Phase 1 & 2 Paired [***]* 2546 Coxsackievirus A & B Abs Evaluation [***]* 2546C Coxsackievirus A & B Abs Evaluation CSF [***]* 2546P Coxsackievirus A & B Abs EvaIuation Paired [***]* 2536 Coxsackievirus A Abs, Serotypes 7,9,10,16 [***]* 2536C Coxsackievirus A Abs, Serotypes 7,9,10,16 CSF [***]* 2541 Coxsackievirus B Abs, Serotypes 1-6 [***]* 2541C Coxsackievirus B Abs, Serotypes 1-6 CSF [***]* 2541P Coxsackievirus B Abs, Serotypes 1-6 Paired [***]* 3140 C-Peptide [***]* 3140U C-Peptide Urine [***]* 1535 C-Reactive Protein [***]* 1535C C-Reactive Protein CSF [***]* 1536 C-Reactive Protein UltraQuant [***]* 3851 Creatine Kinase Isoenzymes (CK) [***]* 3976 Creatine Phosphokinase [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 14 1320 Creatinine [***]* 1320U Creatinine 24hr Urine [***]* 1322 Creatinine Clearance [***]* 2490 Creutzfeldt-Jakob Disease DetectR [***]* 1151 Cryofibrinogen [***]* 1152 Cryofibrinogenemia Reflexive Evaluation [***]* 1150 Cryofibrinogens with Reflex [***]* 1158 Cryoglobulin & Cryofibrinogen [***]* 1157 Cryoglobulinemia Reflexive Evaluation [***]* 1155 Cryoglobulins with Reflex [***]* 9099 Cryptococcus Abs [***]* 9099C Cryptococcus Abs CSF [***]* 9189 Cryptococcus Ag [***]* 9189C Cryptococcus Ag CSF [***]* 9189U Cryptococcus Ag Urine [***]* 2439 Cryptosporidium Ag Detection [***]* 4940 Cycloserine [***]* 4940P Cycloserine Peak & Trough [***]* 4313 Cyclosparine A [HPLC] [***]* 4309 Cyclosporine A and Metabolites Serum [FPIA] [default] [***]* 4311 Cyclosporine A and Metabolites Whole Blood [FPIA] [default] [***]* 4315 Cyclosporine G [HPLC] [***]* 1138 Cystatin C [***]* 9816 Cysticercus IgG Abs [***]* 9816C Cysticercus IgG Abs CSF [***]* 9816CS Cysticercus IgG Abs Evaluation [Serum & CSF] [***]* 5917 Cytokeratin Autoabs [***]* 2421 Cytomegalovirus Ag Detection [***]* 8562 Cytomegalovirus CNS Infection AccuDx [***]* 2418 Cytomegalovirus Culture [***]* 7575 Cytomegalovirus DNA Detector [***]* 9430 Cytomegalovirus DNA UltraQuant [***]* 9436 Cytomegalovirus IgG & IgM Abs [default] [***]* 9436C Cytomegalovirus IgG & IgM Abs CSF [***]* 9436P Cytomegalovirus IgG & IgM Abs Paired [***]* 9431 Cytomegalovirus IgG Abs [***]* 9431C Cytomegalovirus IgG Abs CSF [***]* 9431P Cytomegalovirus IgG Abs Paired [***]* 9431CP Cytomegalovirus IgG Abs Paired CSF [***]* 8560 Cytomegalovirus IgG Antibody Index [***]* 2486 Cytomegalovirus IgM Abs [***]* 2486C Cytomegalovirus IgM Abs CSF [***]* 2486P Cytomegalovirus IgM Abs Paired [***]* 2106U Cytomegalovirus immediate-early Ag Urine [***]* 2106 Cytomegalovirus Immediate-early Ag Whole Blood [***]* 2551 Cytomegalovirus Total Abs [***]* 2551C Cytomegalovirus Total Abs CSF [***]* 4200 D-Dimer [***]* 3146 Dehydroepiandrosterone [***]* 3150 Dehydmepiandrosterone-Sulfate [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 15 4956 Delavirdine MonitR [***]* 7646 Dengue Virus IgM Abs [***]* 7646C Dengue Virus IgM Abs CSF [***]* 7646P Dengue Virus IgM Abs Paired [***]* 7646CP Dengue Virus IgM Abs Paired CSF [***]* 7601 Dengue Virus Total Abs [***]* 7601C Dengue Virus Total Abs CSF [***]* 7601P Dengue Virus Total Abs Paired [***]* 3973 Deoxypyridinoline Cross-links [***]* 1276 Deoxyribonucleoprotein Autoabs [***]* 4920 Desalkylflurazepam [***]* 4922 Desipramine [Norpramin] [***]* 1031 Diabetes Evaluation [***]* 1032 Diabetes Mellitus Autoantibody Evaluation [***]* 1036 Diabetes, Genetic Evaluation [***]* 4926 Diazepam [Valium] [***]* 4957 Didanosine (ddl) MonitR [***]* 4120 Digitoxin [***]* 4122 Digoxin [***]* 1415P Diphtheria Toxoid IgG Abs Pro/Post Vaccination [***]* 1415 Diphtheria Toxoid IgG Abs Single Serum [***]* 3351 Direct LDL [***]* 3127 Disaccharidases [***]* 4124 Disopyramide [***]* 5980 Disseminated lntravascular Coagulapathy Evaluation [***]* 5400NI DNA Analysis [FC, No Interpretation] [***]* 5402NI DNA Analysis [IA. No Interpretation] [***]* 1201 DNA Autoabs, Double-stranded [***]* 1290 DNA Autoabs, Single-stranded [***]* 5402 DNA Ploidy [***]* 5400U DNA Ploidy & Cell Cycle Analysis Bladder/Urine [***]* 5400BK DNA Ploidy & Cell Cycle Analysis Block [***]* 5400FZ DNA Ploidy & Cell Cycle Analysis Frozen [***]* 4924 Doxepin & Nordoxepin [***]* 4125 Drugs of Abuse Screen Serum [***]* 4125U Drugs of Abuse Screen Urine [***]* 8181 Eastern Equine Encephalitis IgM Abs [***]* 8181C Eastern Equine EncephaIitis IgM Abs CSF [***]* 8181P Eastern Equine Encephalitis IgM Abs Paired [***]* 7840 Eastern Equine Encephalitis IgM Antibody Index [***]* 8936 Eastern Equine Encephalitis Total Abs [***]* 8936C Eastern Equine Encephalitis Total Abs CSF [***]* 8936P Eastern Equine Encephalitis Total Abs Paired [***]* 8936CP Eastern Equine Encephalitis Total Abs Paired CSF [***]* 8451 Echinococcus IgG Abs [***]* 8451C Echinococcus IgG Abs CSF [***]* 8460 Echinococcus IgG Antibody Index [***]* 8456 Echinococcus IgG, IgM & IgE Abs [default] [***]* 8456C Echinococcus IgG, IgM & IgE Abs CSF [***]* 8456P Echinococcus IgG, IgM & IgE Abs Paired [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 16 2566 Echovirus Abs, Serotypes 4,9,11 & 30 [***]* 2566C Echovirus Abs, Serotypes 4,9,11 & 30 CSF [***]* 2566P Echovirus Abs, Serotypes 4,9,11 & 30 Paired [***]* 7848 Ehrlichia chaffeensis (HME) & E equi (HGE) IgG & IgM Abs Ev [***]* 7851 Ehrlichia chaffeensis (HME) IgG & IgM Abs, [default] [***]* 7851P Ehrlichia chaffeensis IgG & IgM (HME) Abs, Paired [***]* 7848P Ehrlichia chaffeensis (HME) & E. equi(HGE) IgG & IgM Abs Pair [***]* 7844 Ehrlichia equi IgG & IgM (HGE) Abs [***]* 7846 Ehrlichiosis (Granulocytic) & Lyme Disease Evaluation [***]* 1225 EJ Autoantibodies [***]* 3556 Elastase Abs [***]* 5316 Electrolyte Panel [***]* 1580 Electrophoresis, Protein [***]* 1580C Electrophoresis, Protein CSF [***]* 1580U Electrophoresis, Protein Urine Random [***]* 2726 Encephalitis Viral Abs [***]* 2726C Encephalitis Viral Abs CSF [***]* 2726P EncephaIitis Viral Abs Paired [***]* 2726CP Encephalitis Viral Abs Paired CSF [***]* 1191 Endomysial IgA Autoabs [***]* 3622 Endothelin [***]* 3624 Endotoxin Plasma [***]* 4949 Enoxacin [***]* 9016 Entamoeba histolytica Abs [***]* 9016P Entamoeba histolytica Abs Paired [***]* 5695 Entamoeba histolytica Ag Detection [***]* 1346 Entamoeba histolytica IgG Abs [***]* 1346P Entamoeba histolytica IgG Abs Paired [***]* 8441 Entamoeba histolytica IgG, IgM & IgA Abs [default] [***]* 8441C Entamoeba histolytica IgG, IgM & IgA Abs CSF [***]* 8441P Entamoeba histolytica IgG, IgM & IgA Abs Paired [***]* 2901 Entamoeba histolytica Total Abs [***]* 2901C Entamoeba histolytica Total Abs CSF [***]* 2901CP Entamoeba histolytica Total Abs Paired CSF [***]* 3904 Eosinophil Cationic Protein [***]* 3270U Epinephrine 24hr Urine [***]* 3270 Epinephrine Plasma [***]* 7583 Epstein-Barr Virus DNA Detector [***]* 7584 Epstein-Barr Virus DNA UltraQuant [***]* 2131 Epstein-Barr Virus Early Ag (EA) IgA Abs [***]* 2131F Epstein-Barr Virus Early Ag (EA) IgA Abs Fluid [***]* 2131P Epstein-Barr Virus Early Ag (EA) IgA Abs Paired [***]* 2126F Epstein-Barr Virus Early Ag (EA) IgG Abs, diff/rest Fluid [***]* 2126P Epstein-Barr Virus Early Ag (EA) IgG Abs, diff/rest Paired [***]* 2126 Epstein-Barr Virus EarIy Ag (EA) IgG Abs, diff/rest patterns [***]* 2211 Epstein-Barr Virus EvaIuation [default] [***]* 2211E Epstein-Barr Virus Evaluation, Fluid [***]* 2211P Epstein-Barr Virus Evaluation, Paired [***]* 2266 Epstein-Barr Virus Nuclear Ag (EBNA) IgG Abs [***]* 2266F Epstein-Barr Virus Nuclear Ag (EBNA) IgG Abs Fluid [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 17 2266P Epstein-Barr Virus Nuclear Ag (EBNA) IgG Abs Paired [***]* 2271 Epstein-Barr Virus Nuclear Ag (EDNA) IgM Abs [***]* 2271F Epstein-Barr Virus Nuclear Ag (EBNA) lgM Abs Fluid [***]* 2271P Epstein-Barr Virus Nuclear Ag (EBNA). lgM Abs Paired [***]* 8981 Epstein-Barr Virus Viral Capsid Ag (VCA) IgA Abs [***]* 8981F Epstein-Barr Virus Viral Capsid Ag (VCA) IgA Abs Fluid [***]* 8981P Epstein-Barr Virus Viral Capsid Ag (VCA) IgA Abs Paired [***]* 2122 Epstein-Barr Virus Viral Capsid Ag (VCA) IgG & IgM Abs [***]* 2116 Epstein-Barr Virus Viral Capsid Ag (VCA) IgG Abs [***]* 2116F Epstein-Barr Virus Viral Capsid Ag (VCA) IgG Abs Fluid [***]* 2116P Epstein-Barr Virus Viral Capsid Ag (VCA) IgG Abs Paired [***]* 2121 Epstein-Barr Virus Viral Capsid Ag (VCA) IgM Abs [***]* 2121F Epstein-Barr Virus Viral Capsid Ag (VCA) IgM Abs Fluid [***]* 2121P Epstein-Barr Virus Viral Capsid Ag (VCA) lgM Abs Paired [***]* 5180 Erythrocyte Sedimentation Rate [***]* 1160 Erythropoietin [***]* 5640 Escherichia coli 0157:H7 Culture Confirmation [***]* 5642 Escherichia coli Enteroinvasive Toxin [***]* 5639 Escherichis coli Enteropathogenic Stool Culture [***]* 5645 Escherichia coli Enteropathogenic Toxin [***]* 5643 Escherichia coli Enterotoxigenic Toxin [***]* 2381 Escherichia coli K1 / N. meningitidis Type B Ag [***]* 2381C Escherichia coii K1 / N. meningitidis Type B Ag CSF [***]* 2381U Escherichia coli K1 / N. meningitidis Type B Ag Urine [***]* 5641 Escherichia coli Pathogenicity Evaluation for Diarrhea [***]* 5644 Escherichia coli Verotoxin [***]* 3155 Estradiol [***]* 3158 Estriol, Total [***]* 3158U Estriol, Total 24hr Urine [***]* 3156 Estriol, Unconjugated [***]* 3162 Estrogen & Progesterone Receptor Frozen [ELA] [***]* 1830 Estrogen & Progesterone Receptor Paraffin [IHC] [***]* 1831 Estrogen Receptor [***]* 3164 Estrogens, Total (default] [***]* 3154 Estrone [***]* 3148 Estrone Sulfate [***]* 4942 Ethambutol [***]* 4942P Ethambutol Peak & Trough [***]* 4913 Ethionamide [***]* 4913P Ethionamide Peak & Trough [***]* 4126 Ethosuximide [***]* 1210 Extractable Nuclear Ag (ENA) IgG Autoabs [***]* 5920 F-actin IgG Autoabs [***]* 5983 Factor Deficiency Detector [***]* 1941 Factor II Activity [***]* 1949 Factor IX Activity [***]* 1964 Factor IX Ag [***]* 1943 Factor V Activity [***]* 1966 Factor V Mutation (Leiden) [***]* 1945 Factor VII Activity [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 18 1947 Factor VIII Activity [***]* 1967 Factor VIII Inactivator [***]* 1951 Factor X Activity [***]* 1965 Factor X Ag [***]* 1953 Factor XI Activity [***]* 1955 Factor XII Activity [***]* 1957 Factor XIII Activity Qual w/reflex Quantitation [***]* 8426 Fasciola IgG & lgM Abs [***]* 8426C Fasciola IgG & IgM Abs CSF [***]* 8426P Fasciola IgG & IgM Abs Paired [***]* 8421 Fasciola IgG Abs [EIA] [***]* 8431 Fasciola IgG Abs [IB] [***]* 8421C Fasciola IgG Abs CSF [***]* 8421P Fasciola IgG Abs Paired [***]* 9101 Febrile Agglutinins [***]* 9101P Febrile Agglutinins Paired [***]* 4426 Fecal Fat (Lipids), Qualitative [***]* 4428 Fecal Fat Acid Steatocrit [***]* 4427 Fecal Fat, Quantitative [***]* 2960 Fecal Leukocytes [***]* 3170 Ferritin [***]* 4976AF Fetal Hemoglobin, Quantitative Amniotic Fluid [***]* 4204 Fibrin Monomer, Soluble [***]* 4204 Fibrin Monomer, Soluble [***]* 4208 Fibrin Split Products [***]* 1426 Fibrinogen [***]* 5977 Fibrinolysis Evaluation [***]* 9301 Filaria IgG & IgM Abs [***]* 9301C Filaria IgG & IgM Abs CSF [***]* 9301P Filaria IgG & IgM Abs Paired [***]* 9306 Filaria IgG4 Abs [***]* 2360 Filaria Organism Detection [***]* 4921 Flecainide [FPIA] [***]* 4904 Fluconazole [***]* 4904P FIuconazole Peak & Trough [***]* 4950 Fluoxetine & Norfluoxetine [Prozac] [***]* 3522 Folate [***]* 3522B Folate RBC [***]* 3174 Follicle-Stimulating Hormone [***]* 2020 Follicle-Stimulating Hormone & Luteinizing Hormone Eval [***]* 5362 Fragile X DNA Probe Analysis [SB/PCR] [***]* 5364 Fragile X DNA Probe Analysis with Chromosome Analysis [***]* 5364 Fragile X DNA Probe Analysis with Chromosome Analysis [***]* 8171 Francisella tularensis IgG, IgM & IgA Abs [default] [***]* 8171C Francisella tularensis IgG, IgM & IgA Abs CSF [***]* 8171P Francisella tularensis IgG, IgM & IgA Abs Paired [***]* 8166 Francisella tularensis Total Abs [Agglutinins] [***]* 3934 Fructosamine [***]* 2731 Fungal Abs [CF] [default] [***]* 2731C Fungal Abs [CF] CSF [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 19 2731P Fungal Abs [CF] Paired [***]* 7221C Fungal Abs [EIA] CSF [***]* 2780 Fungal Antibody Panel: Invasive [***]* 2785 Fungal Antibody Panel: Opportunistic [***]* 2785C Fungal Antibody Panel: Opportunistic CSF [***]* 2790 Fungal Antibody Panel: Systemic [***]* 2790C Fungal Antibody Panel: Systemic CSF [***]* 7221 Fungal IgG & IgM Abs [EIA] [***]* 7224 Fungal IgG Abs [***]* 7224C Fungal IgG Abs CSF [***]* 5322 Fungus Culture & Stain [***]* 5779 Fungus Culture: Yeast Screen [***]* 5324 Fungus Identification [***]* 5690 Fungus Identification, Exoantigen [***]* 2940 Fungus Identification, rRNA [***]* 2941 Fungus Stain [***]* 5662FC Fungus Susceptibility: Custom MIC & MFC-5-Fluorocytosine [***]* 5662AM Fungus Susceptibility: Custom MIC & MFC-Amphotericin B [***]* 5662FL Fungus Susceptibility: Custom MlC & MFC-Fluconazole [***]* 5662IT Fungus Susceptibility: Custom MIC & MFC-Itraconazole [***]* 5662KE Fungus Susceptibility: Custom MIC & MFC-Ketoconazole [***]* 5662Ml Fungus Susceptibility: Custom MIC & MFC-Miconazole [***]* 5662NY Fungus Susceptibility: Custom MIC &. MFC-Nystatin [***]* 5661FC Fungus Susceptibility: Custom MIC-5-Fluorocytosine [***]* 5661AM Fungus Susceptibility: Custom MIC-Amphotericin B [***]* 5661FL Fungus Susceptibility: Custom MIC-Fluconazole [***]* 5661IT Fungus Susceptibility: Custom MIC-Itraconazole [***]* 5661KE Fungus Susceptibility: Custom MIC-Ketoconazole [***]* 5661MI Fungus Susceptibility: Custom MIC-Miconazole [***]* 5661NY Fungus Susceptibility: Custom MIC-Nystatin [***]* 5660 Fungus Susceptibility: MIC Panel [***]* 8476 FUO Ab PANEL [***]* 3364 Gabapentin [***]* 4011 Ganglioside Asialo-GM1 Autoabs [***]* 4011C Ganglioside Asialo-GM1 Autoabs CSI [***]* 4056 Ganglioside Autoabs Evaluation [***]* 4006 Ganglioside GD1a Autoabs [***]* 4041 Ganglioside GEM Autoabs [***]* 4041C Ganglioside GD1b Autoabs CSF [***]* 4058 Ganglioside GM1 Triple Evaluation [***]* 4043 Ganglioside GQ1b Autoabs [***]* 1441 Ganglioside MonosiaIic Acid Autoabs [***]* 1441C Ganglioside Monosialic Acid Autoabs CSF [***]* 5778 Gardnerella vaginalis & Grp S Streptococcus Culture Screen [***]* 1599 Gastric pH [***]* 3176 Gastrin [***]* 4901 Gentamicin [***]* 4901P Gentamicin Peak & Trough [***]* 5302 GGT [***]* 2473 Giardia / Cryptosporidium Ag Detection [DFA) [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 20 7526 Giardia / Cryptosporidium Ag Detection [EIA] [***]* 7760 Giardia lamblia Ag Detection [***]* 7726 Giardia lamblia IgG Abs [***]* 7751 Giardia lamblia IgG, IgM & IgA Abs [***]* 7751C Giardia lamblia IgG, IgM & IgA Abs CSF [***]* 7751P Giardia lamblia IgG, IgM & IgA Abs Paired [***]* 7762 Giardiasis Evaluation [***]* 2948 Giemsa Stain [***]* 1286 Gliadin IgA Abs [***]* 1266 Gliadin IgG & IgA Abs [default] [***]* 1266P Gliadin IgG & IgA Abs Paired [***]* 1261 Gliadin IgG Abs [***]* 1051 Glial Fibrillary Acidic Protein Autoabs [GFAP] [***]* 1136 Glomerular Basement Membrane IgG Autoabs [***]* 3616 Glucagon [***]* 5301 Glucose [***]* 5301P Glucose, Plasma [***]* 1398 Glucose-6-Phosphate Dehydrogenase [G-6-PDH] [***]* 1693 Glycophorin-A [***]* 3181 Glycosylated Albumin [***]* 2438 Gram Stain [***]* 1622 Granulocyte Autoabs [***]* 1621 Granulocyte Colony Stimulating Factor [***]* 3182 Growth Hormone [***]* 2955 Haemophilus ducreyi Culture [***]* 9606 Haemophilus influenzae b Ag [***]* 9606C Haemophilus influenzae b Ag CSF [***]* 9606U Haemophilus influenzae b Ag Urine [***]* 9861P Haemophilus influenzea b IgG Abs Pre/Post Vaccination [***]* 9861 Haemophilus influenzae b IgG Abs Single Serum [***]* 5637 Haemophilus influenzae Serotyping [***]* 7506 Hantavirus Hantaan & Puumala IgG & IgM Abs [***]* 7506P Hantavirus Hantaan & Puumala IgG & IgM Abs Paired [***]* 7507 Hantavirus Hantaan & Puumala IgG Abs [***]* 7507P Hantavirus Hantaan & Puumala IgG Abs Paired [***]* 7508 Hantavirus Hantaan & Puumala IgM Abs [***]* 7508P Hantavirus Hantaan & Puumala IgM Abs Paired [***]* 7501 Hantavirus Hantaan IgG & IgM Abs [***]* 7501P Hantavirus Hantaan IgG & IgM Abs Paired [***]* 7496 Hantavirus Puumala IgG & IgM Abs [***]* 7496P Hantavirus Puumala IgG & IgM Abs Paired [***]* 1517 Haptoglobin [***]* 3864 Head & Neck Cancer Monitor [***]* 3864SR Head & Neck Cancer Monitor w/Serial Graphics [***]* 4080U Heavy Metal Screen 24hr Urine [***]* 4080W Heavy Metal Screen Blood [***]* 2403 Helicobacter pylori Culture [***]* 7458 Helicobacter pylori Cytotoxin A IgG Abs [***]* 7744 Helicobacter pylori Evaluation [***]* 7742 Helicobacter pylori EvaluatR [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 21 7986 Helicobacter pylori IgA Abs [***]* 7761 Helicobacter pylori IgG Abs [***]* 7761P Helicobacter pylori IgG Abs Paired [***]* 7460 Helicobacter pyiori IgG, IgM & IgA Abs and Cytotoxin A IgG [***]* 7741 Helicobacter pylori IgG, IgM, & IgA Abs [default] [***]* 7741P Helicobacter pylori IgG, IgM, & IgA Abs Paired [***]* 7736 Helicobacter pylori IgM Abs [***]* 2443 Helicobacter pylori Specific Ag [***]* 7481 Helicobacter pylori Total Abs [***]* 5369 Hemochromatosis DNA Probe Analysis, Hereditary [***]* 5116 Hemoglobin [***]* 5112 Hemoglobin & Hematocrit [***]* 4972 Hemoglobin A1c, Quantitative [HPLC] [***]* 4974 Hemoglobin A2, Quantitative [***]* 4976 Hemoglobin F, Quant [***]* 4978 Hemoglobin S Screen [***]* 4982 Hemoglobin Variant Screen [***]* 4980 Hemoglobin, Total Glycated [***]* 5964 Hemophilia A Carrier Screen [***]* 5969 Hemophilia B Carrier Screen [***]* 5943 Heparin Antifactor Xa [***]* 5998 Heparin Co-factor II [HCII] [***]* 5318 Hepatic Function Panel [***]* 7756 Hepatitis A & B Virus Acute Evaluation [***]* 2463 Hepatitis A & B Virus Evaluation [***]* 2463P Hepatitis A & B Virus Evaluation Paired [***]* 2451 Hepatitis A Virus IgM Abs [***]* 2451P Hepatitis A Virus IgM Abs Paired [***]* 2460 Hepatitis A Virus Total & IgM Abs [***]* 2450 Hepatitis A Virus Total Abs [***]* 2450P Hepatitis A Virus Total Abs Paired [***]* 2467 Hepatitis A, B, & C Virus Evaluation [***]* 7758 Hepatitis A, B, & C Virus Post Exposure Panel [***]* 8136 Hepatitis B Virus AccuQuant [default] [***]* 2457 Hepatitis B Virus Core IgM Abs [***]* 2457P Hepatitis B Virus Core IgM Abs Paired [***]* 2452 Hepatitis B Virus Core Total Abs [***]* 2452P Hepatitis B Virus Core Total Abs Paired [***]* 8141 Hepatitis B Virus DNA Detector [***]* 8142 Hepatitis B Virus DNA Detector w/ reflex Quantitation [***]* 8143 Hepatitis B Virus DNA Quantitation by Branched DNA [***]* 8137 Hepatitis B Virus DNA UltraQuant [***]* 8137 Hepatitis B Virus DNA UltraQuant [***]* 2461 Hepatitis B Virus Evaluation [***]* 2448 Hepatitis B Virus Surface Ab Quantitation [***]* 2448P Hepatitis B Virus Surface Ab Quantitation, Paired [***]* 2454 Hepatitis B Virus Surface Ag [***]* 2449 Hepatitis B Virus Surface Ag Neutralization [***]* 2454P Hepatitis B Virus Surface Ag Paired [***]* 2470 Hepatitis B Virus Surface Ag without confirmation [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 22 2453 Hepatitis B Virus Surface Total Abs [***]* 2453P Hepatitis B Virus Surface Total Abs Paired [***]* 2456 Hepatitis Be Virus Ag [***]* 2456P Hepatitis Be Virus Ag Paired [***]* 2462 Hepatitis Be Virus Antigen/Antibody Evaluation [***]* 2455 Hepatitis Be Virus Total Abs [***]* 2455P Hepatitis Be Virus Total Abs Paired [***]* 2447 Hepatitis C Virus Abs RIBA Confirmation [***]* 2447B Hepatitis C Virus Abs RIBA Confirmation + bands [***]* 7473 Hepatitis C Virus GenotypR [***]* 2446 Hepatitis C Virus IgG Abs [***]* 2445 Hepatitis C Virus IgG Abs w/ reflex RIBA [***]* 7491 Hepatitis C Virus RIBA Evaluation + reflex PCR [***]* 7486 Hepatitis C Virus RNA AccuQuant [***]* 7476 Hepatitis C Virus RNA AccuQuant reflex GenotypR [***]* 7476SR Hepatitis C Virus RNA AccuQuant rflx GenotypR w/Serial Graph [***]* 7486SR Hepatitis C Virus RNA AccuQuant w/Serial Graphics [***]* 7518 Hepatitis C Virus RNA Detector with reflex Quant [default] [***]* 7516 Hepatitis C Virus RNA DetectR [***]* 7472 Hepatitis C Virus RNA Quantitation by Branched DNA [***]* 7472 Hepatitis C Virus RNA Quantitation by Branched DNA [***]* 8131 Hepatitis Delta Virus Ag [***]* 2459 Hepatitis Delta Virus IgM Abs [***]* 2459P Hepatitis Delta Virus IgM Abs Paired [***]* 2465 Hepatitis Delta Virus Total & IgM Abs [***]* 2465P Hepatitis Delta Virus Total & IgM Abs Paired [***]* 2458 Hepatitis Delta Virus Total Abs [***]* 2458P Hepatitis Delta Virus Total Abs Paired [***]* 2467 Hepatitis E IgG [***]* 2466 Hepatitis E IgG & IgM Evaluation [***]* 2466 Hepatitis E IgG & IgM Evaluation [***]* 2469 Hepatitis E IgM [***]* 2468 Hepatitis G Virus RNA DetectR [***]* 5965 Hereditary Thrombosis Screen A, No Heparin or Coumadin [***]* 5966 Hereditary Thrombosis Screen B, Patients on Coumadin [***]* 7581 Herpes Simplex Virus DNA DetectR [***]* 9474 Herpes Simplex Virus DNA UltraQuant [***]* 9517 Herpes Simplex Virus Encephalitis AccuDx [***]* 9515 Herpes Simplex Virus IgG Antibody Index [***]* 9491 Herpes Simplex Virus SeroDx, Types 1 & 2-specfic IgG Abs [***]* 2571 Herpes Simplex Virus Total Abs [CF] [***]* 2571C Herpes Simplex Virus Total Abs CSF [CF] [***]* 2571P Herpes Simplex Virus Total Abs Paired [CF) [***]* 9476 Herpes Simplex Virus Type 1 IgG & IgM Abs [***]* 9476C Herpes Simplex Virus Type 1 IgG & IgM Abs CSF [default] [***]* 9476P Herpes Simplex Virus Type 1 IgG & IgM Abs Paired [***]* 9476CP Herpes Simplex Virus Type 1 IgG & IgM Abs Paired CSF [***]* 9451 Herpes Simplex Virus Type 1 IgG Abs [***]* 9451C Herpes Simplex Virus Type 1 IgG Abs CSF [***]* 9451P Herpes Simplex Virus Type 1 IgG Abs Paired [***]* 9451CP Herpes Simplex Virus Type 1 IgG Abs Paired CSF [***]* 9456 Herpes Simplex Virus Type 1 IgM Abs [***]* 9456C Herpes Simplex Virus Type 1 IgM Abs CSF [***]* 9456P Herpes Simplex Virus Type 1 IgM Abs Paired [***]* 9456CP Herpes Simplex Virus Type 1 IgM Abs Paired CSF [***]* 9481 Herpes Simplex Virus Type 2 IgG & IgM Abs [***]* 9481C Herpes Simplex Virus Type 2 IgG & IgM Abs CSF [***]* 9481P Herpes Simplex Virus Type 2 IgG & IgM Abs Paired [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 23 9481CP Herpes Simplex Virus Type 2 IgG & IgM Abs Paired CSF [***]* 9461 Herpes Simplex Virus Type 2 IgG Abs [***]* 9461C Herpes Simplex Virus Type 2 IgG Abs CSF [***]* 9461P Herpes Simplex Virus Type 2 IgG Abs Paired [***]* 9461CP Herpes Simplex Virus Type 2 IgG Abs Paired CSF [***]* 9466 Herpes Simplex Virus Type 2 IgM Abs [***]* 9466C Herpes simplex Virus Type 2 IgM Abs CSF [***]* 9466P Herpes Simplex Virus Type 2 IgM Abs Paired [***]* 9466CP Herpes Simplex Virus Type 2 IgM Abs Paired CSF [***]* 9496 Herpes Simplex Virus Types 1 & 2 AccuDx [EIA] [***]* 2426 Herpes Simplex Virus Types 1 & 2 Ag Detection [DFA] [***]* 2402 Herpes Simplex Virus Types 1 & 2 Culture [***]* 8051 Herpes Simplex Virus Types 1 &. 2 IgG & IgM Abs [default) [***]* 8051C Herpes Simplex Virus Types 1 & 2 IgG & IgM Abs CSF [default] [***]* 8051P Herpes Simplex Virus Types 1 & 2 IgG & IgM Abs Paired [***]* 8051CP Herpes Simplex Virus Types 1 & 2 IgG & IgM Abs Paired CSF [***]* 9446 Herpes Simplex Virus Types 1 & 2 IgG Abs [***]* 9446C Herpes Simplex Virus Types 1 & 2 IgG Abs CSF [***]* 9446P Herpes Simplex Virus Types 1 & 2 IgG Abs Paired [***]* 9446CP Herpes Simplex Virus Types 1 & 2 IgG Abs Paired CSF [***]* 9471 Herpes Simplex Virus Types 1 & 2 IgM Abs [***]* 9471C Herpes simplex Virus Types 1 & 2 IgM Abs CSF [***]* 9471P Herpes Simplex Virus Types 1 & 2 IgM Abs PaneI Paired [***]* 9471CP Herpes Simplex Virus Types 1 & 2 IgM Abs Panel Paired CSF [***]* 7494 Herpesvirus-6 Human DNA DetectR [***]* 7776 Herpesvirus-6 Human Early Ag IgG & IgM Abs [default] [***]* 7776C Herpesvirus-6 Human Early Ag IgG & IgM Abs CSF [***]* 7776P Herpesvirus-6 Human Early Ag IgG & IgM Abs Paired [***]* 7786 Herpesvirus-6 Human Early Ag IgG Abs [***]* 7786C Herpesvirus-6 Human Early Ag IgG Abs CSF [***]* 7786P Herpesvirus-6 Human Early Ag IgG Abs Paired [***]* 7796 Herpesvirus-6 Human Early Ag IgM Abs [***]* 7796C Herpesvirus-6 Human Early Ag IgM Abs CSF [***]* 7796P Herpesvirus-6 Human Early Ag IgM Abs Paired [***]* 7777 Herpesvirus-7, Human IgG & IgM Abs [***]* 7775 Herpesvirus-7, Human IgG Abs [***]* 7778 Herpesvirus-7, Human IgM Abs [***]* 7784 Herpesvirus-8, Human Antibodies [***]* 7785 Herpesvirus-8, Human DNA DetectR [***]* 9095 Heterophile Agglutination [***]* 3188 Hirsutism Evaluation, Female [***]* 3354 Histamine [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 24 1140 Histone-DNA CompIex IgG Autoabs [***]* 2581 Histoplasma Abs [CF] [default] [***]* 2581C Histoplasma Abs [CF] CSF [***]* 2581P Histoplasma Abs [CF] Paired [***]* 2334 Histoplasma Abs [DD] [***]* 2334C Histoplasma Abs [DD] CSF [***]* 7587 Histoplasma DNA DetectR [***]* 7705 Histoplasma IgG Antibody Index [***]* 8311 Histoplasma IgG, IgM & IgA Abs [default] [***]* 8311C Histoplasma IgG IgM & IgA Abs CSF [***]* 8311P Histoplasma IgG IgM & IgA Abs Paired [***]* 9919 HIV 1 & 2 IgG Abs [EIA] w/rfx HIV 1 & 2 IgG Abs [IB] [***]* 9919B HIV 1 & 2 IgG Abs [EIA] w/rfx HIV 1 & 2 IgG Abs [IB] + bands [***]* 9918 HIV-1 & 2 IgG Abs [EIA] [***]* 3015 HIV-1 & 2 IgG Abs Confirmation [lB] [***]* 3013E HIV-1 Abs Confirmation + bands w/ reflex to HIV-2 + bands [***]* 3012 HIV-1 Abs Confirmation ImmunobIot [***]* 3012B HIV-1 Abs Confirmation lmmunoblot + bands [***]* 9866 HIV-1 Ag Neutralization Confirmation Test [***]* 9866C HIV-1 Ag Neutralization Confirmation Test CSF [***]* 9882 HIV-1 Ag without Neutralization [***]* 5721AZT HIV-1 Anti-Viral Drug Study: AZT IC50 Value [***]* 5723 HIV-1 Anti-Viral Drug Study: Phenotypic Resistance [***]* 5725 HIV-1 Culture, Qualitative [***]* 5727 HIV-1 Culture, Quantitative [***]* 5729 HIV-1 Culture, Quantitative Plasma [***]* 9885 HIV-1 DNA DetectR [default] [***]* 9885N HIV-1 DNA DetectR Non-blood [***]* 9845 HIV-1 Encephalopathy Evaluation [***]* 9848 HIV-1 Free & Total Ag [***]* 9881 HIV-1 Free Ag [default] [***]* 9881C HIV-1 Free Ag CSF [***]* 7479 HIV-1 GenotypR (Protease Inhibitor) [***]* 7477 HIV-1 GenotypR (Reverse Transcriptase Inhibitor) [***]* 7480 HIV-1 GenotypR PLUS ( Rev Trans & Prot Inhib ) [default] [***]* 3016 HIV-1 IgG Abs w/ reflex IB [***]* 3016B HIV-1 IgG Abs w/ reflex IB + bands [***]* 9870 HIV-1 IgG Antibody Index [***]* 3080 HIV-1 immune Status Monitor [***]* 7478NY HIV-1 RNA Quant by Roche reflex HIV GenotypR (RTI) New York [***]* 7482FPNY HIV-1 RNA Quant by Roche reflex HIV GenotypR PLUS New York [***]* 7482NY HIV-1 RNA Quant by Roche reflex HIV GenotypR PLUS New York [***]* 7483A HIV-1 RNA Quant by Roche reflx Ultrasens + GenotypR (PI) [***]* 9874A HIV-1 RNA Quant by Roche reflx Ultrasensitive [***]* 7478A HIV-1 RNA Quant by Roche rflx Ultrasensitive+GenotypR (RTI) [***]* 7482A HIV-1 RNA Quant by Roche rfx to UItrasensitive+GenotypR PLUS [***]* 7485A HIV-1 RNA Quant by Roche Ultrasensitive [***]* 9886 HIV-1 RNA Quantitation by Branched DNA [***]* 9886NY HIV-1 RNA Quantitation by Branched DNA (New York) [***]* 9886NY HIV-1 RNA Quantitation by Branched DNA (New York) [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 25 9884NYP HIV-1 RNA Quantitation New York Prognostic [***]* 9874 HIV-1 RNA UltraQuant [***]* 9874 HIV-1 RNA UltraQuant [***]* 9872 HIV-1 RNA UltraQuant & CD4 Cell Count [***]* 9872SR HIV-1 RNA UltraQuant & CD4 Cell Count w/Serial Report [***]* 9874NY HIV-1 RNA UltraQuant New York [***]* 9874NY HIV-1 RNA UltraQuant New York [***]* 9874FPNY HIV-1 RNA UltraQuant New York (Flat Fee) [***]* 7478 HIV-1 RNA UltraQuant reflx to HIV GenotypR (RTI) [***]* 7483 HIV-1 RNA UltraQuant reflx to HIV GenotypR (PI) [***]* 7483NY HIV-1 RNA UltraQuant reflx to HIV GenotypR (PI) New York [***]* 7482 HIV-1 RNA UltraQuant reflx to HIV GenotypR PLUS (RTI & PI) [***]* 7483FPNY HIV-1 RNA UltraQuant rfx HIV GenotypR PI New York (Flat Fee) [***]* 9874SR HIV-1 RNA UltraQuant With Serial Reporting [***]* 9846 HIV-1 Total Ag, Immune CompIex Disruption (ICD) [***]* 9876 HIV-2 DNA DetectR [***]* 9921 HIV-2 IgG Abs w/ reflex 1B [***]* 9921B HIV-2 IgG Abs w/ reflex IB + bands [***]* 9921C HIV-2 IgG Abs w/ reflex IB CSF [***]* 9921NY HIV-2 IgG Abs w/ reflex IB New York [***]* 9926 HIV-2 IgG Abs, Confirmation [***]* 9926B HIV-2 IgG Abs, Confirmation + bands [***]* 1349 HLA: A & B Typing, Complete [***]* 1356 HLA: A or B Typing (specify antigen) [***]* 1700 HLA: A, B, & C Abs [***]* 1351 HLA: A, B, & C Typing, Complete [***]* 1035 HLA: A, B, C, & D Typing, Complete [***]* 1350 HLA: B27 Typing [***]* 1362 HLA: B5 (B51 & B52) Typing [***]* 1354 HLA: B8 - Primary Sclerosing Cholangitis [***]* 1355 HLA- Diabetes-associated [***]* 1352 HLA: DR Typing, Complete [***]* 1706 HLA: DR2 & DQ1 - Narcolepsy Evaluation [***]* 1357 HLA: DR2 OR DR4 (specify antigen) [***]* 1353 HLA: DR3 - Celiac Disease [***]* 1358 HLA: DRB1 - Rheumatoid Arthritis [***]* 3334 Homocyst(e)ine UltraQuant [***]* 3334U Homocyst(e)ine UltraQuant Urine [***]* 3946 Homovanillic Acid, 24hr Urine [***]* 3947 Homovanillic Acid, Pediatric [***]* 9898 HTLV I / II IgG Abs [***]* 9898C HTLV I / II IgG Abs CSF [***]* 9899 HTLV I / II IgG Abs wl reflex HTLV l / II IB + bands [***]* 7780 HTLV I / II Abs Confirmation [***]* 7780E HTLV I / II Abs Confirmation + bands [***]* 7780CB HTLV I / II Abs Confirmation + bands CSF [***]* 7780C HTLV I / II Abs Confirmation CSF [***]* 9896 HTLV I / II DNA DetectR [***]* 5915 Human Anti-Mouse Abs [***]* 3184 Human Chorionic Gonadotropin [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 26 3184C Human Chorionic Gonadotropin CSF [***]* 3184F Human Chorionic Gonadotropin Fluid [***]* 3184SR Human Chorionic Gonadotropin w/Serial Graphics [***]* 1638 Human Mixed Lymphocyte Reaction, One Way [MLR] [***]* 1639 Human Mixed Lymphocyte Reaction, Two Way [MLR] [***]* 1820 Human Papillomavirus DetectR [***]* 1824 Human Papillomavirus DetectR reflx to GenotypR [***]* 1822 Human Papillomavirus GenotypR [***]* 1825 Human Papillomavirus Typing [***]* 3186 Human Placental Lactogen [***]* 1086 Humoral Immune Eval + H. influenzae b [***]* 1086P Humoral Immune Eval + H. influenzae b Pre/Post Vacc [***]* 1086/12 Humoral Immune Eval + Pneumo 12 & H. influenzae b [***]* 1086P/12 Humoral Immune Eval + Pneumo 12 & H. influenzae b Pre/Post [***]* 1043 Humoral Immune Evaluation [***]* 1043/12 Humoral Immune Evaluation (Pneumo 12) [***]* 1043P/12 Humoral Immune Evaluation (Pneumo 12) Pre/Post Vacc [***]* 1043P Humoral Immune Evaluation Pre/Post Vacc [***]* 1048/12 Humoral Immune Status Survey (Pneumo 12) [***]* 1048P/12 Humoral Immune Status Survey (Pneumo 12) Pre/Post Vacc [***]* 1048 Humoral Immune Status Survey (Pneumo 4) [***]* 1048PR Humoral Immune Status Survey (Pneumo 4) Pre/Post Repeat [***]* 1048P Humoral Immune Status Survey (Pneumo 4) Pre/Post Vacc [***]* 1301P Humoral Immune Status Survey + Opsonophag Pre/Post Vacc [***]* 1301 Humoral lmmune Status Survey + Opsonophagocytosis [***]* 1481 Hyaluronic Acid [***]* 1481E Hyaluronic Acid Fluid [***]* 3261 Hyperaldosteronism Evaluation [***]* 8157 Hypersensitivity Evaluation II [***]* 8156 Hypersensitivity Pneumonitis Evaluation [***]* 3264 Hypertension lV: Cushing Syndrome Evaluation [***]* 1506 IgA [***]* 1498 IgA (Autoantibodies) IgG & IgM Ab Panel [***]* 1498C IgA (Autoantibodies) IgG & IgM Ab Panel CSF [***]* 1498P IgA (Autoantibodies) IgG & IgM Ab Panel Paired [***]* 1896 IgA (Ioc) [***]* 1506U IgA 24hr Urine [***]* 1431 IgA Fibronectin Aggregates & Serum IgA [***]* 1506F IgA Fluid [***]* 1436 IgA Nephropathy Evaluation [***]* 1931 IgA Subclasses 1 & 2 [***]* 1931P IgA Subclasses 1 & 2 Paired [***]* 1045C IgA IgG & IgM lmmunoglobulin Quantitation CSF [***]* 1045 IgA IgG, & IgM Immunoglobulin Quantitation [***]* 1466 IgA Low Concentrations (< 1.1 mg/dl) [***]* 1466c iga, low concentrations (< 1.1 mg/dl) csf [***]* 1145 igd [***]* 1145e igd fluid [***]* * portions of this page have been omitted pursuant to a request for confidential treatment and filed separately with the securities and exchange commission. page 27 1245 IgE [***]* 1245E IgE Fluid [***]* 1505 IgG [***]* 15050 IgG 24hr Urine [***]* 1505C IgG CSF [***]* 1505F IgG Fluid [***]* 1625 IgG Subclass 1 [***]* 1627 IgG Subclass 2 [***]* 1628 IgG Subclass 3 [***]* 1629 IgG Subclass 4 [***]* 1623 IgG Subclasses 1, 2, 3, & 4 [***]* 1623CF IgG Subclasses 1, 2, 3, & 4 CSF or Body Fluid [***]* 1623P IgG Subclasses 1, 2, 3, & 4, Paired [***]* 3587 IgG Subclasses 2 & 4 [***]* 1438 IgG-Fibronectin Aggregates [***]* 1508 IgM [***]* 1891 IgM (Ioc) [***]* 1508U IgM 24hr Urine [***]* 1508F IgM Fluid [***]* 1461 IgM, low concentrations < 1.1 mg/dl [***]* 1461c igm, low concentrations < 1.1 mg/dl csf [***]* 4932 imipramine & desipramine [norpramin] [***]* 1401 immune complex assay c1q binding, fluid phase [***]* 1401f immune compiex assay c1q binding, fluid phase fluid [***]* 1403 immune complex assay, poiyethylene glycoi [***]* 1403f immune complex assay, polyethylene glycol fluid [***]* 1230 immune complex assay, raji cell [***]* 1230f immune complex assay, raji cell fluid [***]* 1340 immune status panei - dpt [***]* 1341 immune status panei - mmr [***]* 1585 immuncelectrophoresis with light chain typing [***]* 1585c immunoelectrophoresis with light chain typing csf [***]* 1585u immunoelectrophoresis with light chain typing urine [***]* 3125 immunofixation electrophoresis [***]* 3125c immunofixation electrophoresis csf [***]* 3125u lmmunofixation electrophoresis urine [***]* 1882 immunoglobulin gene rearrangement, heavy-chain jh probe [***]* 1884 immunoglobulin gene rearrangement kappa light-chain probe [***]* 3462 immunoreactive trypsin [***]* 3856 immunosuppressive acidic protein [***]* 4965 indinavir monitr [***]* 7536 infectious gastroenteritis evaluation [***]* 7456 infectious ulcer evaluation [***]* 2016 infertility: endocrine evaluation (female) [***]* 2017 infertility: endocrine evaluation (male) [***]* 8521 influenza evaluation [***]* 8516 influenza virus a & b igg, igm & iga abs [***]* 8516c influenza virus a & b igg, igm & iga abs csf [***]* 8516p influenza virus a & b igg, igm & iga abs paired [***]* 2586 influenza virus abs, type a [***]* 2586c influenza virus abs, type a csf [***]* 2586p influenza virus abs, type a paired [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 28 2591 Influenza Virus Abs, Type B [***]* 2591C Influenza Virus Abs, Type B CSF [***]* 2591P Influenza Virus Abs, Type B Paired [***]* 2741 Influenza Virus Abs, Types A & B [***]* 2741 P Influenza Virus Abs, Types A & B Paired [***]* 2423 Influenza Virus, Types A & B Detection [***]* 3984 Inhibin [***]* 3984P Inhibin, Paired [***]* 3192 Insulin [***]* 3876 Insulin Antibodies [***]* 3011 Insulin Antibody Evaluation [***]* 3193 Insulin, Free and Bound [***]* 3959 Insulin-like Growth Factor Binding Protein (IGFBP-3) [***]* 3220 Insulin-like Growth Factor I [***]* 3290 Interferon-alpha [***]* 3290C Interferon-alpha CSF [***]* 3295 Interferon-beta Autoabs [***]* 3292 Interferon-gamma [***]* 3868 Interleukin-1 beta [***]* 3868C Interleukin-1 beta CSF [***]* 3816 Interleukin-1 ra [***]* 3823 Interleukin-10 [***]* 3812 Interleukin-12 [***]* 3870 Interleukin-2 [***]* 3870C Interleukin-2 CSF [***]* 3832 Interleukin-2 Receptor, Soluble [***]* 3832SF Interleukin-2 Receptor, Soluble Synovial Fluid [***]* 3814 Interleukin-4 [***]* 3828 Interleukin-6 [***]* 3829 Interleukin-7 [***]* 3822 Interleukin-8 [***]* 3822BW Interleukin-8 Bronchial Wash [***]* 3196 Intrinsic Factor Blocking Autoabs [***]* 3532 Iron [***]* 3534 Iron Binding Capacity + % Saturation [***]* 3536 Iron Liver Tissue [***]* 3069 Islet Cell Autoabs Evaluation [***]* 3066 Islet Cell Autoantibodies, Complement Fixing [***]* 1165 Islet Cell IgG Cytoplasmic Antibodies [***]* 3356 Isohemagglutinin Titer [***]* 4915 Isoniazid [***]* 4915P Isoniazid Peak & Trough [***]* 4905 Itraconazole [***]* 4905P Itraconazole Peak & Trough [***]* 7641 Japanese Encephalitis Virus IgM Abs [***]* 7641C Japanese Encephalitis Virus IgM Abs CSF [***]* 7641P Japanese EncepheIitiis Virus IgM Abs Paired [***]* 7641CP Japanese Encephalitis Virus IgM Abs Paired CSF [***]* 7590 Japanese Encephalitis Virus IgM Antibody Index [***]* 7596 Japanese Encephalitis Virus Total Abs [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 29 7596C Japanese Encephalitis Virus Total Abs CSF [***]* 1207 Jo-1 Abs [DD] [***]* 1208 Jo-1 IgG Autoabs [EIA] [default] [***]* 1281 Jo-1 IgG Autoabs [IB] [***]* 1741U Kappa & Lambda Light Chain, Quant 24hr Urine [***]* 1731U Kappa Light Chain, Quant 24hr Urine [***]* 1422 Keratin Autoantibodies IgG [IFA] [***]* 4906 Ketoconazole [***]* 4906P Ketoconazole Peak & Trough [***]* 5997 Kiniogen, High Molecular Weight [HMWK] [***]* 1222 Ku Autoantibodies [***]* 3452 Lactate Dehydrogenase [***]* 3453 Lactate Dehydrogenase (LD) Isoenzymes [***]* 4128 Lactic Acid Plasma [***]* 1736U Lambda Light Chain, Quant 24hr Urine [***]* 4966 Lamivudine (3TC) MonitR [***]* 4196 Lamotrigine [***]* 4861U Lead 24hr Urine [***]* 4861I Lead lndustrial (OSHA) Whole Blood [***]* 4861 Lead Serum [***]* 4861W Lead Whole Blood [***]* 2152 Legionella micdadei & L. longbeachae IgG & IgM Abs [***]* 2422 LegioneIla pneumophila Ag Detection [***]* 9601 Legionella pneumophila Ag Detection Urine [***]* 2920 Legionella pneumophila DNA DetectR [***]* 2432 Legionella pneumophila Evaluation [***]* 2153 Legionella pneumophila IgG & IgM Abs, Serotypes 1-14 [***]* 2156 Legionella pneumophila IgG & IgM Abs, Serotypes 1-6 [***]* 2156F Legionella pneumophila IgG & IgM Abs, Serotypes 1-6 Fluid [***]* 2156P Legionella pneumophila IgG & IgM Abs, Serotypes 1-6 Paired [***]* 2154 Legionella pneumaphila IgG Abs, Serotypes 1-14 [***]* 2159 Legionella pneumophila IgM Abs, Serotypes 1-14 [***]* 8245 Legionella pneumophila Total Abs, Pooled Serotypes 1-6 [***]* 8246C Legionella pneumophila Total Abs, Pooled Serotypes CSF [***]* 8246P Legionetla pneumophila Total Abs, Pooled Serotypes Paired [***]* 2404 Legionella spp. Culture [***]* 3420 Leishmania Total Abs [***]* 2398 Leptospira Culture & Darkfield Microscopy [***]* 7821 Leptospira IgG & IgM Abs [default] [***]* 7521C Leptospira IgG & IgM Abs CSF [***]* 7621P Leptospira IgG & IgM Abs Paired [***]* 7546 Leptospira IgG Abs [***]* 7551 Leptospira IgM Abs [***]* 7626 Leptospirosis Evaluation [***]* 1670 Leukemia / Lymphoma Blood Evaluation [***]* 1672 Leukemia / Lymphoma Blood Reflexive Evaluation [***]* 1667 Leukemia / Lymphoma Bone Marrow Evaluation [***]* 1673 Leukemia / Lymphoma Bone Marrow Reflexive Evaluation [***]* 1674 Leukemia / Lymphoma Evaluation Blood [***]* 1679 Leukemia / Lymphoma Evaluation Bone Marrow or Tissue [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 30 3045 Leukemia / Lymphoma Monitor [***]* 3045SR Leukemia / Lymphoma Monitor w/Serial Graphics [***]* 1682 Leukemia / Lymphoma Panel, Chronic Bone Marrow or Tissue [***]* 1675 Leukemia / Lymphoma Panel, Chronic Whole Blood [***]* 1666 Leukemia / Lymphoma Tissue or Body Fluid Evaluation [***]* 1676 Leukemia / Lymphoma, Comprehensive Blood [***]* 1677 Leukemia / Lymphoma, Comprehensive Bone Marrow or Tissue [***]* 3320 L-Glutamine [***]* 4130 Lidocaine [***]* 3369 Lipase [***]* 3369U Lipase, Urine [***]* 3858 Lipid-Associated Sialic Acid [***]* 3858SR Lipid-Assodiated Sialic Acid w/Serial Graphics [***]* 3446 Lipoprotein (a) [***]* 8841 Listeria monocytogenes Abs [***]* 8841C Listeria monocytogenes Abs CSF [***]* 8841P Listeria monocytogenes Abs Paired [***]* 8251 Listeria monocytogenes IgG Abs [***]* 8251C Listeria monocytogenes IgG Abs CSF [***]* 8251C Listeria monocytogenes IgG Abs CSF [***]* 8251P Listeria monocytogenes IgG Abs Paired [***]* 7685 Listeria monocytogenes IgG Antibody Index [***]* 4871U Lithium 24hr Urine [***]* 4871 Lithium Serum [***]* 5922 Liver Cytosol Autoabs [***]* 1115 Liver-Kidney-Microsome Autoabs [***]* 5923 Liver-Specific Membrane Lipoprotein Autoabs [***]* 1094 lupus Activity Reporter [***]* 1911 Lupus Anticoagulant: DRWT [***]* 1915 Lupus Anticoagulant: Hexagonal Phase [***]* 1914 Lupus Anticoagulant: Platelet Neutralization [***]* 5963 Lupus Anticoagulant: Screen 1 [***]* 5976 Lupus Anticoagulant: Screen 2 [***]* 5962 Lupus Anticoagulant: Screen 3 [***]* 5036 Lupus CNS Evaluation [***]* 1057 Lupus CNS Evaluation CSF &. Serum [***]* 5150 Lupus Erythematosus Cell Preparation [***]* 1096 Lupus Monitor [***]* 5045 Lupus Pregnancy Monitor [***]* 5021 Lupus Renal Evaluation #1 [***]* 5022 Lupus Renal Evaluation #2 [***]* 5031 Lupus Renal Evaluation A [***]* 5023 Lupus Renal Evaluation B [***]* 3198 Luteinizing Hormone [***]* 8968 Lyme Co-infection Panel [***]* 2871P Lymphadenopathy Panel Paired [***]* 2871 Lymphadenopathy, Infectious IgM Abs evaluation [***]* 1062 Lymphocyte Antigen & Mitogen Proliferation Analysis [***]* 1648 Lymphocyte Antigen Proliferation Analysis [***]* 1643 Lymphocyte Antigen proliferation Analysis, Candida [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 31 1645 Lymphocyte Antigen proliferation Assays, PPD (Tuberculin) [***]* 1644 Lymphocyte Antigen proliferation Assays, Tetanus [***]* 1671 Lymphocyte Enumeration, Basic [***]* 1669 Lymphocyte Enumeration, Basic & HIV-1 Abs [***]* 1668 Lymphocyte Enumeration, Basic & NK Cells [***]* 1656 Lymphocyte Enumeration, Helper/Inducer [***]* 1656NY Lymphocyte Enumeration, Helper/Inducer without CBC [***]* 1657 Lymphocyte Enumeration, Helper/Suppressor [***]* 1659 Lymphocyte Enumeration, Helper/Suppressor (Limited) [***]* 1667NY Lymphocyte Enumeration, Helper/Supressor without CBC [***]* 1658 Lymphocyte Enumeration, T & B Cell [***]* 1655 Lymphocyte Enumeration, T Cell [***]* 12995W Lymphocyte Isolation and Cryopreservation [***]* 1060 Lymphocyte Mitogen Proliferation Analysis [***]* 1642 Lymphocyte Mitogen Proliferation Analysis, ConA [***]* 1640 Lymphocyte Mitogen Proliferation Analysis, PHA [***]* 1641 Lymphocyte Mogen Proliferation Analysis, PWM [***]* 14505W Lymphocytes Isolation and Storage [***]* 2601 Lymphocytic Choriomeningitis Abs [***]* 2601C Lymphocytic Choriomeningitis Abs CSF [***]* 2601P Lymphocytic Choriomeningitis Abs Paired [***]* 2606 Lymphogranuloma Venereum Abs [***]* 2606C Lymphogranuloma Venereum Abs CSF [***]* 2606P Lymphogranuloma Venereum Abs Paired [***]* 8061 Lymphogranulome Venereum Abs Panel [***]* 8061P Lymphogranuloma Venereum Abs Panel Paired [***]* 4103 Lysergic Acid Diethylamide (LSD) Screen [***]* 4103U Lysergic Acid Diethylamide (LSD) Screen, Urine [***]* 4070 Lysosomal-associated Membrane Protein IgG Autoantibodies [***]* 3882 Macrophage Inflammatory Protein-1 alpha [***]* 3883 Macrophage Inflammatory Protein-1 beta [***]* 4866U Magnesium 24hr Urine [***]* 4866R Magnesium RBC [***]* 4866 Magnesium Serum [***]* 8371C Malaria Antibodies IgG & IgM Abs CSF [EIA] [***]* 8371P Malaria Antibodies IgG, IgM Abs Paired (EIA] [***]* 8370 Malaria DNA DetectR [***]* 8371 Malaria IgG & IgM Abs [***]* 2945 Malaria Organism Detection [***]* 4872 Manganese [***]* 4872U Manganese 24hr Urine [***]* 4872R Manganese RBC [***]* 4872UR Manganese Urine Random [***]* 4872W Manganese Whole Blood [***]* 3830 Mannose-binding Protein [***]* 8771 Measles IgG &. IgM Abs [default] [***]* 8771C Measles IgG & IgM Abs CSF [***]* 8771P Measles IgG & IgM Abs Paired [***]* 8771CP Measles IgG & IgM Abs Paired CSF [***]* 8776 Measles IgG Abs [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 32 8776C Measles IgG Abs CSF [***]* 8776P Measles IgG Abs Paired [***]* 8776CP Measles IgG Abs Paired CSF [***]* 8600 Measles IgG Antibody Index [***]* 8781 Measles IgM Abs [***]* 8781C Measles IgM Abs CSF [***]* 8781C Measles IgM Abs CSF [***]* 8781P Measles IgM Abs Paired [***]* 8781P Measles IgM Abs Paired [***]* 8781CP Measles IgM Abs Paired CSF [***]* 8781CP Measles IgM Abs Paired CSF [***]* 4994 Megaloblastic Anemia AssessR [***]* 3857 Melanoma Monitor [***]* 3857SR Melanoma Monitor w/Serial Graphics [***]* 2771 Meningoencephalomyelitis ViraI Ab evaluation [***]* 2771C Meningoencephalomyelitis Viral Ab Evaluation CSF [***]* 2771CS Meningoencephalomyelitis Viral Ab Evaluation CSF & Serum [***]* 2771P Meningoencephalomyelitis Viral Ab Evaluation Paired [***]* 2771CP Meningoencephalomyelitis Viral Ab Evaluation Paired CSF [***]* 4873U Mercury 24hr Urine [***]* 4873 Mercury Serum [***]* 4873UI Mercury Urine industrial [***]* 4873W Mercury Whole Blood [***]* 5315 Metabolic Panel, Basic [***]* 5317 Metabolic Panel, Comprehensive [***]* 3315 Metanephrines, Fractionated 24hr Urine [***]* 3316 Metanephrines, Total 24hr Urine [***]* 4134U Methadone Urine [***]* 4135 Methotrexate [***]* 3496 Methylmalonic Acid [***]* 3496U Methylmalonic Acid Urine [***]* 3241 MI-2 Autoantibodies [***]* 4909 Miconazole [***]* 4909P Miconazole Peak & Trough [***]* 3442 Microalbumin Random Urine [***]* 5720 Microsporidia Spore Stain [***]* 4165 Minerals Analysis RBC w/ K+ [***]* 1102 Mitochondrial Total Autoabs [***]* 4021 Motor & Sensory Neuropathy Evaluation [***]* 4021C Motor & Sensory Neuropathy Evaluation CSF [***]* 4020 Motor & Sensory Neuropathy EvaluatR [***]* 4036 Motor Neuropathy - Limited [***]* 4026 Motor Neuropathy Evaluation [***]* 2050 MRZ Reaction Evaluation [***]* 1055 Multiple Sclerosis Evaluation [***]* 9711 Mumps IgG & IgM Abs [***]* 9711C Mumps IgG & IgM Abs CSF [***]* 9711P Mumps IgG & IgM Abs Paired [***]* 9711CP Mumps IgG & IgM Abs Paired CSF [***]* 9716 Mumps IgG Abs [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 33 9716C Mumps IgG Abs CSF [***]* 9716P Mumps IgG Abs Paired [***]* 9716CP Mumps IgG Abs Paired CSF [***]* 9725 Mumps IgG Antibody Index [***]* 9721 Mumps IgM Abs [***]* 9721C Mumps IgM Abs CSF [***]* 9721P Mumps IgM Abs Paired [***]* 9721CP Mumps IgM Abs Paired CSF [***]* 1025 Myasthenla Gravis Evaluation [***]* 2435 Mycobacterial DNA DetectR [***]* 7471 Mycobacterial DNA Speciation [***]* 7470 Mycobacterium tuberculosis GenotypR [***]* 4910 Mycophenolic Acid [***]* 2399 Mycoplasma hominis Culture [***]* 2406 Mycoplasma pneumoniae culture [***]* 2924 Mycoplasma pneumoniae DNA DetectR [***]* 8662 Mycoplasma pneumoniae Encephalitis AccuDx [***]* 8731 Mycoplasma pneumoniae IgA Abs [***]* 8731C Mycoplasma pneumoniae IgA Abs CSF [***]* 8731P Mycoplasma pneumoniae IgA Abs Paired [***]* 8741 Mycoplasma pneumoniae IgG & IgM Abs [***]* 8741C Mycoplasma pneumoniae IgG & IgM Abs CSF [***]* 8741P Mycoplasma pneumoniae IgG & IgM Abs Paired [***]* 8741CP Mycoplasma pneumoniae IgG & IgM Abs Paired CSF [***]* 8746 Mycoplasma pneumoniae IgG Abs [***]* 8746C Mycoplasma pneumoniae IgG Abs CSF [***]* 8746P Mycoplasma pneumoniae IgG Abs Paired [***]* 8746CP Mycoplasma pneumoniae IgG Abs Paired CSF [***]* 8660 Mycoplasma pneumoniae IgG Antibody Index [***]* 8736 Mycoplasma pneumoniae IgG, IgM & IgA Abs SeroDx [default] [***]* 8736C Mycoplasma pneumoniae IgG, IgM & IgA Abs SeroDx CSF [***]* 8736P Mycoplasma pneumoniae IgG, IgM & IgA Abs SeroDx Paired [***]* 8751 Mycoplasma pneumoniae IgM Abs [***]* 8751C Mycoplasma pneumoniae IgM Abs CSF [***]* 8751P Mycoplasma pneumoniae IgM Abs Paired [***]* 8751CP Mycoplasma pneumoniae IgM Abs Paired CSF [***]* 1056 Myelin Basic Protein Autoantibodies [MBP] [***]* 1056C Myelin Basic Protein Autoantibodies CSF [MBP-CSF] [***]* 3900 Myelin Basic Protein CSF [***]* 4051 Myelin-Assoc Glycoprot & Sulfoglucuronyl Paragloboside Eval [***]* 4061 Myelin-Associated Glycoprotein (MAG) Autoabs [***]* 1926P Myelin-Associated Glyooprotein (MAG) IgM Abs Paired [***]* 1926 Myelin-Associated Glycoprotein (MAG) IgM Autoabs [***]* 1926C Myelin-Associated Glycoprotein (MAG) IgM Autoabs CSF [***]* 1386 Myeloperoxidase Autoabs [***]* 1103 Myocardial Total Autoabs [***]* 4988 Myoglobin [***]* 4988UR Myoglobin Urine Random [***]* 8666 Myopericarditis Viral Antibodies Evaluation [***]* 8666C Myopericarditis Viral Antibodies Evaluation CSF [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 34 8666P Myopericarditis Viral Antibodies Evaluation Paired [***]* 3240 Myositis AssessR [***]* 3242 Myositis AssessR Plus JO-1 Autoantibodies [***]* 1523 N-Acetyl-B-D-Glucosaminidase [***]* 5421 Natural Killer Cell & LAK Cell Function [***]* 5422 Natural Killer Cell Evaluation [default] [***]* 5420 Natural Killer Cell Function [default] [***]* 1872 Natural Kilter Cell Quantitation [***]* 2516 Neisseria gonorrhoeae Abs [***]* 2516C Neisseria gonorrhoeae Abs CSF [***]* 2516P Neisseria gonorrhoeae Abs Paired [***]* 2478 Neisseria gonorrhoeae Ag Detection [EIA] [***]* 2414 Neisseria gonorrhosae Culture [***]* 2930 Neisseria gonorrhoeae Detection rRNA [***]* 2932 Neisseda gonorrhoeae DNA LCR [***]* 9611 Neisseria meningitidis A,B,C,Y,W135 Ag Detection [***]* 9611C Neisseria meningitidis A,B,C,Y,W135 Ag Detection CSF [***]* 9611U Neisseria meningitidis A,B,C,Y,W135 Ag Detection Urine [***]* 7611 Neisseria meningitidis Abs, Group A & C [***]* 4951 Nelfinavir MonitR [***]* 3282 Neopterin [***]* 3282C Neopterin CSF [***]* 4137 Netilmicin [***]* 3172 Neuroblastoma Monitor [***]* 3172SR Neuroblastoma Monitor w/Serial Graphics [***]* 7960 Neuroborreliosis AccuDx [***]* 7960SF Neuroborreliosis AccuDx, Synovial Fluid [***]* 7965 Neuroborreliosis Evaluation [***]* 1052 Neurofilament-heavy Subunit [NF-H] Autoabs [***]* 1198 Neuronal IgG Autoabs for CNS Lupus [***]* 1198C Neuronal IgG Autoabs for CNS Lupus CSF [***]* 1198CS Neuronal IgG Autoabs for CNS Lupus Serum & CSF [***]* 1186 Neuronal Nuclear Abs Type 1 (Hu) [***]* 1186C Neuronal Nuclear Abs Type 1 (Hu) CSF [***]* 1168 Neuronal Nuclear IgG Abs Type 1 (Hu) [***]* 1168C Neuronal Nuclear IgG Abs Type 1 (Hu) CSF [***]* 1168CS Neuronal Nuclear IgG Abs Type 1 (Hu) Serum & CSF [***]* 3860 Neuron-specific Enolase [***]* 3860C Neuron-specific Enolase CSF [***]* 3860SR Neuron-speciffic Enolase w/Serial Graphics [***]* 1384 Neutrophil Function: Activation (PMA) [***]* 1383 Neutrophil Function: Adherence [CD11a, CD11b, CD11c, CD18] [***]* 3884 Neutrophil Function: Chemotactic Factor Generation [***]* 1382 Neutrophil Function: Myeloperoxidase [***]* 1385 Neutrophil Function: Phagocytosis (Zymosan) [***]* 4954 Nevirapine MonitR [***]* 1618 Nitroblue Tebazolium Assessment [***]* 9620 NMP22 Bladder Tumor Marker [***]* 8151 Nocardia IgG Abs [***]* 8151C Nocardia IgG Abs CSF [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 35 8151P Nocardia IgG Abs Paired [***]* 4928 Nordiazepam [Zofran] [***]* 4948 Norfloxacin [***]* 4948P Norfloxacin Peak & Trough [***]* 4930 Nortriptyline [***]* 4266U N-Telopeptides w/ Creafinine [***]* 5250 Occult Blood (Hemoccult) [***]* 4944 Ofloxacin [***]* 4944P Ofloxacin Peak & Trough [***]* 1223 OJ Autoantibodies [***]* 5910 OKT3 (Anti-) IgG Abs [***]* 5912 OKT3 Ab Quantitation [***]* 1559 Oligoclonal Immunoglobulins [AE] [***]* 1557 Oligoclonal lmmunoglobulins [lEF/lFIX] [***]* 4138U Opiates Urine [***]* 1381P Opsonophagocytosis, Haemophilus influenzae b Paired [***]* 1381 Opsonophagocytosis, HaemophiIus influenzae b whole bacteria [***]* 3204 Osmololity Serum [***]* 3204U Osmolalfy Urine [***]* 3550 Osteocalcin [***]* 7452 Osteoporosis EvaluatR [***]* 7447 Osteoporosis Monitor [***]* 2367 Ova & Parasite: Arthropod Identification [***]* 2363 Ova & Parasite: Coccidia Evaluafion [***]* 2362 Ova & Paresite.- Comprehensive Exam w/ Coccidis Evaluation [***]* 2361 Ova & Parasite: Routine Exam [***]* 2368 Ova & Parasite: Worm Identification [***]* 3038BK Ovarian Cancer Prognosis - Paraffin [***]* 1178 Ovary IgG Autoabs [***]* 4332U Oxalate 24hr Urine [***]* 4332UR Oxalate Random Urine [***]* 4934 Oxazepam [Serax] [***]* 4923 p-AminosaIicylic Acid [***]* 4923P p-Aminosalicylic Acid Peak & Trough [***]* 1866 PAN-ANCA Evaluation [***]* 1868 PAN-ANCA PLUS [***]* 2621 Parainfluenza Virus Types 1-3 Abs [***]* 2621C Parainfluenza Virus Types 1-3 Abs CSF [***]* 2621P Parainfluenza Virus Types 1-3 Abs Paired [***]* 2424 Parainfluenza Virus Types 1-3 Detection [***]* 2746 Paralytic Viral Ab Evaluation [***]* 2746C ParaIytic ViraI Ab Evaluation CSF [***]* 2746P ParaIytic Viral Ab Evaluation Paired [***]* 1171 ParaneopIastic Syndrome Evaluation [***]* 1171C PeraneopIastic Syndrome Evaluation CSF [***]* 1171CS Paraneoplasbc Syndrome Evaluation Serum & CSF [***]* 1104 Parietal Cell Total Autoabs [***]* 3895 Partial Thromboplastin Time (PTT) [***]* 3897 Partial Thromboplastin Time LA [***]* 3898 Partial Thromboplastin Time LA Mixing Studies [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 36 3896 Partial Thromboplastin Time Mixing Studies [***]* 8266 Parvovirus B19 DNA DetectR [***]* 8261 Parvovirus B19 Evaluation [***]* 8261 C Parvovirus B19 Evaluation CSF [***]* 8261 P Parvovirus B19 Evaluation Paired [***]* 8221 Parvovirus B19 IgG & IgM Abs [EIA] [default] [***]* 8221C Parvovirus B19 IgG & IgM Abs [EIA] CSF [***]* 8221P Parvovirus B19 IgG & IgM Abs [EIA] Paired [***]* 8236 Parvovirus B19 IgG & IgM Abs [lB] [***]* 8236C Parvovirus B19 IgG &. IgM Abs [lB] CSF [***]* 8236P Parvovirus B19 IgG & IgM Abs [lB] Paired [***]* 7580 PCR Special Handling [***]* 1421 Perinuclear Factor Autoabs [***]* 4992 Pernicious Anemia AssessR [***]* 4140U Phencyclidine Urine [***]* 4142 Phenobarbital [***]* 4144 Phenytoin Free & Total [***]* 3262 Pheochromocytoma Evaluation [***]* 1771 Phosphatidic Acid IgG, IgM & IgA Abs [***]* 1771C Phosphatidic Acid IgG, IgM & IgA Abs CSF [***]* 1771P Phosphatidic Acid IgG, IgM & IgA Abs Paired [***]* 1751 Phosphatidylcholine IgG, IgM & IgA Abs [***]* 1751C PhosphatidylchoIine IgG, IgM & IgA Abs CSF [***]* 1751P Phosphatidylcholine IgG, Ig & IgA Abs Paired [***]* 1791 Phosphatidylethanolamine IgG, IgM & IgA Abs [***]* 1791C Phosphatidylethanolamine IgG, IgM & IgA Abs CSF [***]* 1791P Phosphatidylethenolamine IgG, IgM & IgA Abs Paired [***]* 1775 PhosphatidyIglycerol IgG, IgM, and IgA Autoantibodies [***]* 1774 Phosphatidylinositol IgG, IgM, and IgA Autoantibodies [***]* 1711 Phosphatidylsedne IgG, IgM & IgA Autoantibodies [***]* 1711C Phosphatidylserine IgG, IgM & IgA Autoantibodies CSF [***]* 1711P Phosphatidyiserine IgG, IgM & IgA Autoantibodies Paired [***]* 5308 Phosphorus Inorganic [***]* 8158 Pigeon Serum Antibodies [***]* 1224 PL-12 Autoantibodies [***]* 1226 PL-7 Autoantibodies [***]* 1492 PIasminogen Activity [***]* 1491 Plasminogen, Quantitative [***]* 5946AD Platelet Aggregation, ADP [***]* 5946AR PIatelet, Aggregation, Arachidonic Acid [***]* 5946CO Platelet Aggregation, Collagen [***]* 5946EP Platelet Aggregation, Epinephrine [***]* 5946RT Platelet Aggregation, Ristocetin [***]* 5946SP Platelet Aggregation Spontaneous [***]* 1636 Platelet Autoabs Evaluation [***]* 5940 Platelet Autoabs, Drug-induced including Heparin [***]* 5995 Platelet Autoantbodies, Comprehensive [***]* 5160 Platelet Count [***]* 5942 Platelet Factor 4 [***]* 5967 Platelet Function Evaluation [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 37 5931 Platelet Glycoprotein Ib/IX IgG, IgM & IgA Autoabs [***]* 5930 Platelet Glycoprotein llb/IlIa IgG, IgM & IgA Autoabs [***]* 1631 Platelet IgG, IgM & IgA Autoabs [***]* 1630 Platelet-associated IgG, IgM & IgA Autoabs [***]* 1257 PM-Scl Autoabs [***]* 7745 Pneumocystis carinii Ag Detection [***]* 8091 Poliovirus Abs [***]* 8091P Poliovirus Abs Paired [***]* 2626 Poliovlrus Abs Serotypes 1-3 [default] [***]* 2626C Poliovirus Abs Serotypes 1-3 CSF [***]* 2626P Poliovirus Abs Serotypes 1-3 Paired [***]* 2023 Polycyste Ovary Evaluation [***]* 2676 Polyomavirus Abs [***]* 2676C Polyomavirus Abs CSF [***]* 2676P Polyomavirus Abs Paired [***]* 5311 Potassium [***]* 4874R Potassium RBC [***]* 1549 Prealbumin [***]* 1549P Prealbumin Paired Testing [***]* 5996 Prekallikrein [PKK] [***]* 5996 Prekallikrein [PKK] [***]* 7531 Primary Sclerosing Cholangitis Evaluation [***]* 4146 Primidone [***]* 4148 Procainamide + NAPA [***]* 3163 Progesterone [***]* 1832 Progesterone Receptor [***]* 3206 Prolactin [***]* 1251 Proliferating Cell Nuclear Ag Abs [***]* 4149U Propoxyphene Urine [***]* 4095 Prostaglandin E2 (PGE2) ElA [***]* 3032 Prostate Cancer Monitor [***]* 3032F Prostate Cancer Monitor Fluid [***]* 3032SR Prostate Cancer Monitor w/Serial Graphics [***]* 3546 Prostate-Specific Ag [***]* 3546F Prostate-Specific Ag Fluid [***]* 3546NY Prostate-Specific Ag New York [***]* 3546SR Prostate-Specific Ag w/Serial Graphics [***]* 3547 Prostate-Specific Antigen, Free & Total [***]* 3547SR Prostate-Specific Antigen, Free & Total w/Serial Graphics [***]* 3100 Prostafc Acid Phosphatase [***]* 3100F Prostatic Acid Phosphatase Fluid [***]* 3100SR Prostatic Acid Phosphatase w/Serial Graphics [***]* 3836 Protein C Activity [***]* 5932 Protein C Ag [***]* 5933 Protein C Evaluation 1 [***]* 5988 Protein C Evaluation 2 [***]* 5989 Protein C Evaluation 3 [***]* 3837 Protein S Activity [***]* 5935 Protein S Antigen, Free [***]* 5937 Protein S Antigen, Total [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 38 5938 Protein S Evaluation 1 [***]* 5993 Protein S Evaluation 2 [***]* 5968 Protein S Evaluation 3 [***]* 5994 Protein S Evaluation 4 [***]* 1324 Protein, Total [***]* 1324U Protein, Total 24 hour Urine [***]* 1324C Protein, Total CSF [***]* 1324F Protein, Total Fluid [***]* 1324SF Protein, Total Synovial Fluid [***]* 1396 Proteinase-3 Autoabs [***]* 5939 Prothrombin Fragment 1.2 [***]* 5372 Prothrombin G20210A Mutation [***]* 3892 Prothrombin Time (PT) [***]* 3893 Prothrombin Time Mixing Studies [***]* 7616 Pseudomonas aeruginosa Abs [***]* 3213 PTH, C Terminal & Intact including Ionized & Total Calcium [***]* 3208 PTH, C Terminal, including Ionized & Total Calcium [***]* 3945 PTH, C Terminal, including Total calcium only [***]* 3944 PTH, Intact including Ionized & Total Calcium [default] [***]* 3943 PTH, Intact including Total Calcium only [***]* 3941 PTH, Intact only [***]* 3941 PTH, Intact only [***]* 3211 PTH, Mid-Molecule & Intact, incl. Ionized & Total Calcium [***]* 3209 PTH, Mid-Molecule only [***]* 3210 PTH, Mid-Molecule, including Ionized & Total Calcium [***]* 3990 PTH-related Protein [***]* 1187 Purkinje Cell Cytoplasmic Autoabs Type 1 (Yo) [***]* 1187C Purkinje Cell Cytoplasmic Autoabs Type 1 (Yo) CSF [***]* 1176CS Purkinje Cell Cytoplasmic IgG Abs Type 1 (Yo) Serum & CSF [***]* 1176 Purkinje Cell Cytoplasmic IgG Autoabs Type 1 (Yo) [***]* 1176C Purkinje Cell Cytoplasmic IgG Autoabs Type 1 (Yo) CSF [***]* 4917 Pyrazinamide [***]* 4917P Pyrazinamide Peak & Trough [***]* 3505 Pyridoxal Phosphate (Vitamin B6) [***]* 7441 Pyruvate Dehydrogenase IgG Autoabs [***]* 4150 Quinidine [***]* 3885 Rantes [***]* 2364 Rapid Plasma Reagin [RPR] [***]* 1726 Rapidly Progressive Glomerulonephritis Evaluation [***]* 3700 RAST Food - Pediatric Panel [***]* 3701 RAST Food - Pediatric Panel + Total IgE [***]* 3702 RAST Food Panel [***]* 3703 RAST Food Panel + Total IgE [***]* 3716 RAST Midwest Panel [***]* 3717 RAST Midwest Panel + Total IgE [***]* 3704 RAST Mold Panel [***]* 3705 RAST Mold Panel + Total IgE [***]* 3718 RAST Northeast Panel [***]* 3719 RAST Northeast Panel +Total IgE [***]* 3712 RAST Northern California Panel [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 39 3713 RAST Northern California Panel + Total IgE [***]* 3720 RAST Southeast Panel [***]* 3721 RAST Southeast Panel + Total IgE [***]* 3710 RAST Southern California Panel [***]* 3711 RAST Southern California Panel + Total IgE [***]* 3714 RAST Southwest Panel [***]* 3715 BAST Southwest Panel + Total IgE [***]* 3722 RAST West Coast Panel [***]* 3723 RAST West Coast Panel + Total IgE [***]* F77 RAST-Beta lactoglobulin IgE [***]* M8 RAST-Helminthosporium halodes IgE [***]* 3745 RAST-Phadiatop [***]* RAST1 RAST-Single Allergen [***]* TX7 RAST-Tree Mix: TX7 [***]* 1070 Reactive Arthritis Evaluation [***]* 2028 Recurrent Spontaneous Abortion: Autoimmune Evaluation [***]* 1375 Recurrent Spontaneous Abortion: Crossmatch [***]* 1375P Recurrent Spontaneous Abortion: Crossmatch Paired [***]* 2025 Recurrent Spontaneous Abortion: Endocrine Evaluation [***]* 2026 Recurrent Spontaneous Abortion: Immunology Evaluation [***]* 2027 Recurrent Spontaneous Abortion: Infectious Disease Evaluation [***]* 3214 Renin Activity Plasma [***]* 2641 Reovirus Abs [***]* 2641C Reovirus Antibodies CSF [CF] [***]* 2641P Reovirus Antibodies, Paired CF [***]* 2701 Respiratory Infection Abs, Adult [***]* 2701C Respiratory Infection Abs, Adult CSF [***]* 2701P Respiratory Infection Abs, Adult Paired [***]* 2711 Respiratory Infection Abs, ChiId/Infant [***]* 2711C Respiratory Infection Abs, Child/Infant CSF [***]* 2711P Respiratory Infection Abs, Child/Infant Paired [***]* 2425 Respiratory Infection Evaluation, Viral [***]* 8691C Respiratory Synctyial Virus IgG & IgM Abs CSF [***]* 8691P Respiratory Synctyial Virus IgG & IgM Abs Paired [***]* 2646P Respiratory Synctyial Virus Total Abs Paired [***]* 2646C Respiratory Syncytial Virus Abs CSF [***]* 5697 Respiratory Syncytial Virus Ag Detection [ElA] [***]* 2704 Respiratory Syncytial Virus Detection [DFA] [***]* 8691 Respiratory Syncytial Virus IgG & IgM Abs [***]* 2646 Respiratory Syncytial Virus Total Abs [***]* 1162 Reticulin IgA Autoabs [***]* 1105 Reticulin Total Autoabs [***]* 3236 Reverse Triidothyronine (RT3) [***]* 1004 Rheumatic Evaluation [***]* 5052 Rheumatoid Arthritis Monitor #2 [***]* 5053 Rheumatoid Arthritis Monitor #3 [***]* 5050 Rheumatoid Arthritis Prognosticator [***]* 1015F Rheumatoid Factor (IgM), NEPH & SCAT Titer, IHA Fluid [***]* 1015 Rheumatoid Factor Autoabs Evaluation [***]* 1012 Rheumatoid Factor igG, IgM, & IgA Autoantibodies [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 40 1113 Rheumatoid Factor IgM Autoabs [IHA) [***]* 1540 Rheumatoid Factor IgM Autoabs [Neph] [***]* 1273 Ribosomal P Protein IgG Antibody Index [***]* 1271 Ribosomal P Protein IgG Autoabs [***]* 1271C Ribosomal P Protein IgG Autoabs CSF [***]* 1271CS Ribosomal P Protein IgG Autoabs Serum & CSF [***]* 7951 Rickettsia conorii IgG & IgM Abs [***]* 7951C Rickettsia conorii IgG & IgM Abs CSF [***]* 7951P Rickettsia conorii IgG & IgM Abs Paired [***]* 7876 Rickettsia rickettsii & R. typhi IgG & IgM Abs Eval [***]* 7876C Rickettsia rickettsii & R. typhi IgG & IgM Abs Eval CSF [***]* 7876P Rickettsia rickettsii & R. typhi IgG & IgM Abs Eval Paired [***]* 7871 Rickettsia rickettsii & R. typhi IgG Abs Evaluation [***]* 7881 Rickettsia rickettsii & R. typhi IgM Abs Evaluation [***]* 7896 Rickettsia rickettsii IgG & IgM Abs [***]* 7896C Rickettsia rickettsii IgG & IgM Abs CSF [***]* 7896P Rickettsia rickettsii IgG & IgM Abs Paired [***]* 7886 Rickettsia rickettsii IgG Abs [***]* 7886 Rickettsia rickettsii IgG Abs [***]* 7886P Rickettsia rickettsii IgG Abs Paired [***]* 7891 Rickettsia rickettsii IgM Abs [***]* 7891 Rickettsia rickettsii IgM Abs [***]* 8126 Rickettsia tsutsugamushi IgG Abs [***]* 7911 Rickettsia typhi IgG & IgM Abs [***]* 7901 Rickettsia typhi IgG Abs [***]* 7901P Rickettsia typhi IgG Abs Paired [***]* 7906 Rickettsia typhi IgM Abs [***]* 4919 Rifampin [***]* 4919P Rifampin Peak & Trough [***]* 1871 Ristocetin Cofactor Function [***]* 4952 Ritonavir MonitR [***]* 1494 RNA Polymerases I, II and III IgG Autoabs [***]* 7856 Rotavirus Abs [***]* 7856C Rotavirus Abs CSF [***]* 7856P Rotavirus Abs Paired [***]* 2472 Rotavirus Ag Detection [***]* 9421 Rubella IgG & IgM Abs [default] [***]* 9421C Rubella IgG & IgM Abs CSF [***]* 9421P Rubella IgG & IgM Abs Paired [***]* 9421CP Rubella IgG & IgM Abs Paired CSF [***]* 9416 Rubella IgG Abs [***]* 9416F Rubella IgG Abs Fluid [***]* 9416P Rubella IgG Abs Paired [***]* 9416FP Rubella IgG Abs Paired Fluid [***]* 7770 Rubella IgG Antibody Index [***]* 2475 Rubella IgM Abs [***]* 2475C Rubella IgM Abs CSF [***]* 2475P Rubella IgM Abs Paired [***]* 4152 Salicylate [***]* 7631 Salmonella IgG, IgM & IgA Abs [default] [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 41 7631P Salmonella IgG, IgM & IgA Abs Paired [***]* 5636 Salmonella Serotyping [***]* 4967 Saquinavir MonitR [***]* 1085 Sarcoidosis Evaluation [***]* 8386 Schistosoma Abs Evaluation [***]* 8386P Schistosoma Abs Evaluation Paired [***]* 8326 Schistosoma IgG Abs [***]* 8351 Schistosoma IgG and IgM Abs [***]* 8351P Schistosoma IgG and IgM Abs Paired [***]* 8336 Schistosoma IgG, IgM & IgE Abs [default] [***]* 7656 Schistosoma mansoni IgG Abs [***]* 1235 Scl-70 IgG Autoabs [***]* 4875 Selenium [***]* 4875U Selenium 24hr Urine [***]* 4875UR Selenium Random Urine [***]* 4875R Selenium RBC [***]* 4875W Selenium Whole Blood [***]* 4031 Sensory Neuropathy Evaluation [***]* 4030 Sensory Neuropathy EvaluatR [***]* 4195 Sertraline [Zoloft] [***]* 3218 Sex Hormone Binding Globulin [***]* 2034 Sexually Transmitted Disease Agents [***]* 8576C Shigella Abs [***]* 8576P Shigella Abs CSF [***]* 8576 Shigella Abs Paired [***]* 8581 Shigella IgG Abs [***]* 5636 Shigella Serotyping [***]* 4986 Sickle Cell Screen [***]* 1253 Silicate IgG & IgM Autoabs [***]* 7433 Silicone Sensitivity Detector Panel [***]* 7431 Silicone-specific T-Cell Proliferation Test [***]* 7502 Sin Nombre Virus Antibodies [***]* 1114 Skin Total Autoabs, Inter-epithelial & Dermal-epidermal [***]* 1220 Sm (Smith) IgG Autoabs [***]* 3254 Small-cell Carcinoma Monitor, Lung [***]* 1106 Smooth Muscle Total Autoabs [***]* 5306 Sodium [***]* 1520 Soluble Transferrin Receptor (TfR) [***]* 3222 Somatostatin [***]* 5225P Sperm IgG Abs Paired [***]* 5225 Sperm IgG Autoabs [***]* 9151 Sporothrix Abs [***]* 8286 Sporothrix IgG, IgM & IgA Abs [default] [***]* 8286C Sporothrix IgG, IgM & IgA Abs CSF [***]* 8286P Sporothrix IgG, IgM & IgA Abs Paired [***]* 3862 Squamous Cell Carcinoma Ag [***]* 3862SR Squamous Cell Carcinoma Ag w/Serial Graphics [***]* 3865 Squamous Cell Carcinoma Monitor, Lung [***]* 3865SR Squamous Cell Carcinoma Monitor, Lung w/Serial Graphics [***]* 1227 SRP Autoantibodies [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 42 1007 SS-A & SS-B IgG Autoabs [***]* 1204 SS-A IgG Autoabs [***]* 1205 SS-B IgG Autoabs [***]* 8186 St. Louis Encephalitis IgM Abs [***]* 8186C St. Louis Encephalitis IgM Abs CSF [***]* 8186P St. Louis Encephalitis IgM Abs Paired [***]* 7810 St. Louis Encephalitis IgM Antibody Index [***]* 8921 St. Louis Encephalitis Total Abs [***]* 8921C St. Louis Encephalitis Total Abs CSF [***]* 8921P St. Louis EncephaIitis Total Abs Paired [***]* 8921CP St. Louis Encephalitis Total Abs Paired CSF [***]* 4953 Stavudine (d4T) MonitR [***]* 4155 Stone Analysis, Kidney [***]* 4160 Stone-A-Lyzer [***]* 9641 Streptococcus Group B Ag [***]* 9641C Streptococcus Group B Ag CSF [***]* 9641U Streptococcus Group B Ag Urine [***]* 7861 Streptococcus Group B IgG Abs [***]* 7861C Streptococcus Group B IgG Abs CSF [***]* 7861P Streptococcus Group B IgG Abs Paired [***]* 9636 Streptococcus pneumoniae Ag [***]* 9636C Streptococcus pneumoniae Ag CSF [***]* 9636U Streptococcus pneumoniae Ag Urine [***]* 2386 Streptococcus pneumoniae IgG Abs, 12 Serotypes [***]* 2386P Streptococcus pneumoniae IgG Abs, 12 Serotypes Pre/Post [***]* 2370 Streptococcus pneumoniae IgG Abs, 4 Serotypes [default] [***]* 2370P Streptococcus pneumoniae IgG Abs, 4 Serotypes Pre/Post [***]* 1337 Streptococcus pyogenes, Group A Abs (Streptozyme) [***]* 5777 Streptococcus, Beta Group A Culture Screen [***]* 2433 Streptococcus, Beta Group B Culture Screen [***]* 1107 Striational Total Autoabs [***]* 8566 Strongyloides IgG Abs [***]* 8566C Strongyloides IgG Abs CSF [***]* 8566P Strongyloides IgG Abs Paired [***]* 4016 Sulfatide Autoabs [***]* 4046 Sulfoglucuronyl Paragloboside Autoabs [***]* 3232 T Uptake [***]* 3225 T3 Free, Tracer Dialysis [***]* 5948 Tacrolimus [***]* 4004 Tau-Transferrin [***]* 1880 T-cell Receptor Gene Rearrangement [***]* 2321 Teichoic Acid Abs [***]* 2321F Teichoic Acid Abs Fluid [***]* 2321P Teichoic Acid Abs Paired [***]* 1634 Terminal Deoxynucleotidyl Transferase Bone Marrow or Tissue [***]* 1694 Terminal Deoxynucleotidyl Transferase Bone Marrow or Tissue [***]* 1694W Terminal Deoxynucleotidyl Transferase Whole Blood [***]* 1635 Terminal Deoxynucleotidyl Transferase with Immunophenotyping [***]* 1180 Testes IgG Autoabs [***]* 3247 Testosterone, Free [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 43 3248 Testosterone, Free & Total [default] [***]* 3244 Testosterone, Total [***]* 1331P Tetanus & Diphtheria Toxoid IgG Abs Pre/Post Vaccination [***]* 1331 Tetanus & Diphtheria Toxoid IgG Abs Single Serum [***]* 1334P Tetanus Toxoid IgG Abs Pre/Post Vaccination [***]* 1334 Tetanus Toxoid IgG Abs Single Serum [***]* 4156 Theophylline [***]* 4212 Thrombin Anti-Thrombin [TAT] Complex [***]* 4210 Thrombin Time (TT) [***]* 5978 Thrombotic Markers Evaluation [***]* 5990 Thrombotic Risk AssessR [***]* 5972 Thrombotic Risk Evaluation 1 [***]* 5971 Thrombotic Risk Evaluation 2 [***]* 5973 Thrombotic Risk Evaluation 3 [***]* 3298 Thrombotic Risk Evaluation 4 [***]* 3251 ThyroglobuIin [***]* 1110 Thyroglobulin Autoabs [***]* 3255 Thyroglobulin Serum [***]* 1016 Thyroid Autoabs [***]* 3060 Thyroid Autoabs Evaluation [***]* 3072 Thyroid Panel, Hyperthyroidism [***]* 3074 Thyroid Panel, Hypothyroidism [***]* 3062 Thyroid Peroxidase Autoabs [default] [***]* 3076 Thyroid Screen [***]* 3250 Thyroid Stimulating Hormone, 3rd Generation [***]* 1091 Thyroid Stimulating Immunoglobulins [***]* 1091 Thyroid Stimulating Immunoglobulins [***]* 1091P Thyroid Stimulating Immunoglobulins Paired [***]* 1092 Thyroid Stimulating Immunoglobulins w/o TSH [***]* 1090 Thyrotropin Binding Inhibitory Immunoglobulins [***]* 1093 Thyrotropin Binding Inhibitory Immunoglobulins w/o TSH [***]* 3226 Thyroxine (T4) [***]* 3238 Thyroxine Binding Globulin [***]* 3228 Thyroxine, Free [***]* 3230 Thyroxine, Free Index [***]* 3288 Tissue Plasminogen Activator Ag [***]* 5979 Tissue Plasminogen Activator Evaluation [***]* 5925 Tissue Plasminogen Activator Function [***]* 3296 Tissue Plasminogen Activator Inhibitor [***]* 1002 Tissue Total Autoabs Screen [TABS] [***]* 4902 Tobramycin [***]* 4902P Tobramycin Peak & Trough [***]* 4925 Topiramate [***]* 4925P Topiramate Peak & Trough [***]* 9901 TORCH IgG & IgM Abs Evaluation [***]* 9901P TORCH IgG & IgM Abs Evaluation Paired [***]* 9911 TORCH IgG Abs Evaluation [***]* 9911C TORCH IgG Abs Evaluation CSF [***]* 9911P TORCH IgG Abs Evaluation Paired [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 44 2231 TORCH IgM Abs Evaluation [***]* 2231C TORCH IgM Abs Evaluation CSF [***]* 2231P TORCH IgM Abs Evaluation Paired [***]* 4162 Toxic Element Analysis Whole Blood [***]* 2436 Toxic Shock Syndrome Abs [***]* 2437 Toxic Shock Syndrome Evaluation [***]* 9766 Toxocara IgG Abs [***]* 9766P Toxocara IgG Abs Paired [***]* 9761F Toxocara IgG, IgM & IgA Abs Fluid [***]* 9761P Toxocara IgG, IgM & IgA Abs Paired [***]* 9761FP Toxocara IgG, IgM & IgA Abs Paired Fluid [***]* 9761 Toxocara IgG, IgM, & IgA Abs [default] [***]* 2261 ToxopIasma Antibody Evaluation [default] [***]* 2261C Toxoplasma Antibody Evaluation CSF [***]* 2261F Toxoplasma Antibody Evaluation Fluid [***]* 2261P Toxoplasma Antibody Evaluation Paired [***]* 7521 Toxoplasma DNA DetectR [***]* 8972 Toxoplasma Encephalitis AccuDx [***]* 7666 Toxoplasma IgA Abs [***]* 7666P Toxoplasma IgA Abs Paired [***]* 9426 Toxoplasma IgG Abs [***]* 9426C Toxoplasma IgG Abs CSF [***]* 9426F Toxoplasma IgG Abs Fluid [***]* 9426P Toxoplasma IgG Abs Paired [***]* 8970 Toxoplasma IgG Antibody Index [***]* 7661 Taxoplasma IgM Abs [ISAGA] [***]* 7661C Toxoplasma IgM Abs [ISAGA] CSF [***]* 7661F Toxoplasma IgM Abs [ISAGA] Fluid [***]* 7661P Toxoplasma IgM Abs [ISAGA] Paired [***]* 7675 Toxoplasma IgM Abs [MAC EIA] [default] [***]* 7675C Toxoplasma IgM Abs [MAC EIA] CSF [***]* 7675F Toxoplasma IgM Abs [MAC EIA] Fluid [***]* 7675P Toxoplasma IgM Abs [MAC EIA] Paired [***]* 1519 Transferrin [***]* 4002 Transferrin Genetic D Variants [***]* 1519U Transferrin Urine [***]* 1029 TransgIutaminase IgA Autoabs [EIA] [***]* 1027 TransgIutaminase IgG Autoabs [EIA] [***]* 1030 TransgIutaminase IgG, IgM & IgA Autoabs Evaluation [EIA] [***]* 1028 TransgIutaminase IgM Autoabs [EIA] [***]* 4960 Trazodone [***]* 1537 Treatable Ischemia PredictR (TlP) [***]* 9020 Treponema pallidum Abs, MHA-TP [***]* 7565 Treponema pallidum IgG & IgM Abs [***]* 7565F Treponema pallidum IgG IgM Abs Fluid [***]* 7561 Treponema pallidum IgG Abs [***]* 7561C Treponema pallidum IgG Abs CSF [***]* 7560C Treponema pallidum IgG Antibodies, FTA-ABS Quant CSF [***]* 7560 Treponema pallidum IgG Antibodies, FTA-ABS Quantitative [***]* 7555 Treponema pailidum IgG Antibody Index [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 45 7566 Treponema pallidum IgM Abs [***]* 7566C Treponema pallidum IgM Abs CSF [***]* 2102 Treponema pallidum IgM Abs, FTA-ABS [***]* 2102C Treponema pallidum IgM Abs, FTA-ABS CSF [***]* 2104C Treponema pallidum Total Abs, FTA-ABS [***]* 2104 Treponema pallidum Total Abs, FTA-ABS [DEFAULT] [***]* 2104P Treponema pallidum Total Abs, FTA-ABS Paired [***]* 9386 Trichinella IgG Abs [***]* 9386C Trichinella IgG Abs CSF [***]* 9386P Trichinella IgG Abs Paired [***]* 9386CP Trichinella IgG Abs Paired CSF [***]* 9745 Trichinella IgG Antibody Index [***]* 9741 Trichinella IgG, IgM & IgA Abs [***]* 9741C Trichinella IgG, IgM & IgA Abs CSF [***]* 9741P Trichinella IgG, IgM & IgA Abs Paired [***]* 9741CP Trichinella IgG, IgM & IgA Abs Paired CSF [***]* 4158 Tricyclics Screen [***]* 3346 Triglycerides [***]* 3224 Triiodothyronine (T3) [***]* 3234 Triiodothyronine, Free [***]* 7573 Tropheryma whippelii DNA DetectR [***]* 3390 Troponin (l & T) DetectR [***]* 3393 Troponin l [***]* 3392 Troponin T [***]* 9316 Trypanosoma cruzi IgG Abs [***]* 9316P Trypanosoma cruzi IgG Abs Paired [***]* 3460 Tryptase [***]* 1053 TubuIin Autoabs [***]* 3294C Tumor Necrosis Factor alpha CSF [***]* 3294 Tumor Necrosis Factor-alpha Plasma [***]* 3908 Tumor Necrosis Factor-binding Proteins [***]* 3908C Tumor Necrosis Factor-binding Proteins CSF [***]* 1215 U1 RNP/snRNP IgG Autoabs [***]* 1228 U2 SnRNP Autoantibodies [***]* 5319 Urea Nitrogen [***]* 2408 Ureaplasma urealyticum / Mycoplasma hominis Culture [***]* 1310 Uric Acid [***]* 4333UR Uric Acid Random Urine [***]* 4333U Uric Acid, 24hr Urine [***]* 7439 Ur-Sure Chlamydia trachomatis/Neisseria gonorrhoeae by LCR [***]* 3017 Uterine Cancer Monitor [***]* 3017SR Uterine Cancer Monitor w/Serial Graphics [***]* 3360 Valproic Acid [***]* 3361 Valproic Acid Free [***]* 4903 Vancomycin [***]* 4903P Vancomycin Peak & Trough [***]* 3319 Vanillylmandelic Acid - Pediatric [***]* 3318U Vanillylmandelic Acid, 24hr Urine [***]* 3318UR Vanillylmandelic Acid, Urine Random [***]* 2199 Varicella-zoster Virus Ag Detection [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 46 7585 Varicella-zoster Virus DNA DetectR [***]* 8761 Varicella-zoster Virus IgG Abs [***]* 8761C Varicella-zoster Virus igG Abs CSF [***]* 8761P Varicella-zoster Virus IgG Abs Paired [***]* 8761CP Varicella-zoster Virus IgG Abs Paired CSF [***]* 7980 Varicella-zoster Virus IgG Antibody Index [***]* 8766 Varicella-zoster Virus IgM Abs [***]* 8766C Varicella-zoster Virus IgM Abs CSF [***]* 8766P Varicella-zoster Virus IgM Abs Paired [***]* 8766CP Varicella-zoster Virus IgM Abs Paired CSF [***]* 8756 Varicella-zoster Virus SeroDx, IgG & IgM Abs [default] [***]* 8756C Varicella-zoster Virus SeroDx, IgG & IgM Abs CSF [***]* 8756P Varicella-zoster Virus SeroDx, IgG & IgM Abs Paired [***]* 8756CP Varicella-zoster Virus SeroDx, IgG & IgM Abs Paired CSF [***]* 2576 Varicella-zoster Virus Total Abs [***]* 2576C Varicella-zoster Virus Total Abs CSF [***]* 3252 Vasoactive Intestinal Peptide [***]* 2366 VDRL [***]* 2366C VDRL CSF [***]* 5975 Venous Thromboembolism (VTE) AssessR [***]* 2410 Viral culture [***]* 2442 Viral Diarrhea Ag Detection [***]* 5680 Viral Susceptibility: Acyclovir [***]* 5681 Viral Susceptibility: Foscamet [***]* 5682 Viral Susceptibility: Ganciclovir [***]* 5683 Viral Susceptibility: Penciclovir [***]* 5684 Viral Susceptibility: Vidarabine [***]* 1240P Viscosity Plasma [***]* 1240 Viscosity Serum [***]* 3502 Vitamin A [***]* 3515 Vitamin B1 [***]* 3519 Vitamin B1 & Transketolase [***]* 3515U Vitamin B1 24hr Urine [***]* 3518 Vitamin B1 Functional Assessment [***]* 3515W Vitamin B1 Whole Blood [***]* 3504 Vitamin B12 [***]* 3020 Vitamin B12 & Folate [***]* 3500 Vitamin B2 Functional Assessment [***]* 3508 Vitamin C [***]* 3508U Vitamin C 24hr Urine [***]* 3520 Vitamin D, 1,25-dihydroxy [***]* 3520 Vitamin D, 1,25-dihydroxy [***]* 3521 Vitamin D, 25-hydroxy [***]* 3530 Vitamin E [***]* 4834 Voltage-Gated Calcium Channel IgG Autoabs [***]* 5981 von Willebrand Evaluation [***]* 5982 von Willebrand Evaluation without Ristocetin [***]* 1907 von Willebrand Factor Ag [***]* 1905 von Willebrand Factor Multimers Evaluation [***]* 1906 von Willebrand Multimers [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 47 5961 von Willebrand Profile [***]* 5960 von Willebrand Profile with reflex to Multimers [***]* 9121 Weil-Felix Test [***]* 9121P Weil-Felix Test Paired [***]* 8191 Western Equine Encephalitis IgM Abs [***]* 8191C Western Equine Encephalitis IgM Abs CSF [***]* 8191P Western Equine Encephalitis IgM Abs Paired [***]* 7830 Western Equine Encephalitis IgM Antibody Index [***]* 8931 Western Equine Encephalitis Total Abs [***]* 8931C Western Equine Encephalitis Total Abs CSF [***]* 8931P Western Equine Encephalitis Total Abs Paired [***]* 8931CP Western Equine Encephalitis Total Abs Paired CSF [***]* 9076 WIDAL Evaluation, Salmonella spp. Abs [***]* 9076P WIDAL Evaluation, salmonella spp. Abs Paired [***]* 5702 Yersinia Culture [***]* 8676 Yersinia enterocolitica Abs Serotype 0:3 [***]* 8676C Yersinia enterocolitica Abs Serotype 0:3 CSF [***]* 8676P Yersinia enterocolitica Abs Serotype 0:3 Paired [***]* 8681 Yersinia enterocolitica Abs Serotype 0:8 [***]* 8681C Yersinia enterocolitica Abs Serotype 0:8 CSF [***]* 8681P Yersinia enterocolitica Abs Serotype 0:8 Paired [***]* 8686 Yersinia enterocolitica Abs Serotype 0:9 [***]* 8686C Yersinia enterocolitica Abs Serotype 0:9 CSF [***]* 8686P Yersinia enterocolitica Abs Serotype 0:9 Paired [***]* 8696 Yersinia enterocolitica Abs Serotypes 0:3, 0:8, 0:9 [***]* 8696C Yersinia enterocolitica Abs Serotypes 0:3, 0:8, 0:9 CSF [***]* 8696P Yersinia enterocolitica Abs Serotypes 0:3. 0:8, 0:9 Paired [***]* 8721 Yersinia enterocolitica IgA Abs [***]* 8721C Yersinia enterocolitica IgA Abs CSF [***]* 8721CP Yersinia enterocolitica IgA Abs Paired CSF [***]* 2491 Yersinia enterocolitica IgG Abs [***]* 2491C Yersinia enterocolitica igG Abs CSF [***]* 2491P Yersinia enterocolitica IgG Abs Paired [***]* 2491CP Yersinia enterocolitica IgG Abs Paired CSF [***]* 9751 Yersinia enterocolitica IgG, IgM & IgA Abs [***]* 9751C Yersinia enterocolitica IgG, IgM & IgA Abs CSF [***]* 9751P Yersinia enterocolitica IgG, IgM & IgA Abs Paired [***]* 9751CP Yersinla enterocolitica IgG, IgM & IgA Abs Paired CSF [***]* 2496 Yersinia enterocolitica IgM Abs [***]* 2496C Yersinia enterocolitica IgM Abs CSF [***]* 2496P Yersinia enterocoiitica IgM Abs Paired [***]* 2496CP Yersinia enterocolitica IgM Abs Paired CSF [***]* 8711 Yersinia pseudotubercuiosis Total Abs [***]* 8711 C Yersinia pseudotuberculosis Total Abs CSF [***]* 8711 P Yersinia Pseudotuberculosis Total Abs Paired [***]* 4958 Zalcitabine (ddC) MonitR [***]* 4959 Zidovudine (AZT) MonitR [***]* 4877U Zinc 24hr Urine [***]* 4877PL Zinc Plasma [***]* 3275 Zinc Protoporphyrin [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 48 32751 Zinc Protoporphydh, Industrial [***]* 4877R Zinc RBC [***]* 4877 Zinc Serum [***]*

* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. Page 49 ATTACHMENT C 2000 EXCEPTION LIST
2000 LIST TEST CODE TEST DESCRIPTION PRICE - ------------------------------------------------------------------------------------------------------ 3492 2-Methylcitric Acid [***]* 4558 5,10-Methylenetetrahydrafolate Reductase (MTHFR) C677T Mutation [***]* 4560 5,10-MTHFR C677T Mutation Reflex to A1298C Mutation [***]* 5900 Activated Protein C Resistance [***]* 7589 Adenovirus DNA DetectR [***]* 3090 Alpha-Fetoprotein - Maternal, 2.5 Mom [***]* 3108 Alpha-Fetoprotein - Maternal, Serum [***]* 3111 Alpha-Fetoprotein - Prenatal, Amniotic Fluid [***]* 3092 Alpha-Fetoprotein Quad Screen, 2.5 Mom [***]* 3110 Alpha-Fetoprotein Triple Screen 2.0 (Triple Marker Screen) [***]* 3091 Alpha-Fetoprotein Triple Screen 2.5 (Triple Marker Screen) [***]* 1916 Apo E GenotypR (for all purp except late-onset Alzheimers) [***]* 9525 Arbovirus RNA DetectR [***]* 1358 Arthritis RX SelectR [***]* 7598 Aseptic Meningitis/Encephalitis DetectR [***]* 2628 Atypical Pneumonia DNA DetectR [***]* 8861 Bartonella henselae & B. quintana DNA DetectR [***]* 7511 Bartonella quintana DNA DetectR [***]* 1888 bcl-2 Gene Translocation [SB] [***]* 1890 bcr/abl Gene Rearrangement [SB] [***]* 5350 bcr/abl Gene Translocation [PCR] [***]* 1470 Beryllium-induced Lymphocyte Proliferation [***]* 3575 Beta-Hydroxybutrate [***]* 7570 Borrelia burgdorferi DNA DetectR [***]* 1804 Breast Cancer Profile 1 - Paraffin [***]* 1813 Breast Cancer Profile 2 - Paraffin [***]* 1819 Breast Cancer Profile 3 - Paraffin [***]* 1818 Breast Cancer Profile 3 With Her-2/Neu Reflex [***]* 1817 Breast Cancer Profile 4 - Paraffin [***]* 1812 Breast Cancer Profile 5 - Paraffin [***]* 1811 Breast Cancer Profile 6 - Paraffin [***]* 1816 Breast Cancer Profile 7 - Paraffin [***]* 3999 Carbohydrate-deficient Transferrin, Qualitative [***]* 5368 CC-CKR5 Delta 32 Mutation [***]* 4007 CDT UltraQuant with reflex to Genetic D Variants [***]* 1077 Celiac Disease EvaluatR [***]* 1078 Celiac Disease Genotypr [***]* 2922 Chlamydia pneumoniae DNA DetectR [***]* 2927 Chlamydia trachomatis / Neisseria gonorrhoeae by rRNA [***]* 2925 Chlamydia trachomatis Detection rRNA [***]* 7437 Chlamydia trachomatis DNA LCR [***]* 5832 Chromosome & FISH for Genetic Disorders Evaluation [***]* 5840 Chromosome Analysis: Acute Promyelo Leukemia [***]* 5822 Chromosome Analysis: Amniotic Fluid [***]* 5834 Chromosome Analysis: bcr/abl Gene Rearrangement by FISH [***]* 5814 Chromosome Analysis: Congenital Disorders, Blood [***]* 5830 Chromosome Analysis: FISH for Genetic Diseases [***]* 5800 Chromosome Analysis: Hematological Disorders I [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PAGE 1 OF 7 5810 Chromosome Analysis: Hematological Disorders II [***]* 5836 Chromosome Analysis- HER-2/neu Gene Amplification [***]* 5742 Chromosome Analysis: KAL Gene Deletion by FISH [***]* 5806 Chromosome Analysis: Mosaicism [***]* 5818 Chromosome Analysis: Products of Conception/Skin Biopsies [***]* 5844 Chromosome Analysis: STS Gene Detection [***]* 5812 Chromosome Analysis: Trisomy 12 by FISH [***]* 5808 Chromosome Analysis: Trisomy 8 by FISH [***]* 5838 Chromosome Analysis: X and Y Prove for Opposite Sex Bone Marrow Transplant [***]* 1651 Chronic Fatigue & Immune Dysfunction Syndrome Evaluation [***]* 1652 Chronic Fatigue & Immune Dysfunction Syndrome with NK Cell [***]* 5902 Complement Deficiency Detector Evaluation [***]* 1998 Complement Split Product Concentration: iC3b [***]* 1723 Complement: C3 & C4 Nephritic Factors Evaluation [***]* 2490 Creutzfeldt-Jakob Disease DetectR [***]* 3494 Cystathionine [***]* 5374 Cytochrome P450 2D6 EvaluatR - Poor-Metabolizers [***]* 7575 Cytomegalovirus DNA Detector [***]* 9430 Cytomegalovirus DNA UitraQuant [***]* 9430C Cytomegalovirus Dna Ultraquant CSF [***]* 9430SR Cytomegalovirus DNA Ultraquant w/Serial Graphics [***]* 7574 Cytomegalovirus GenotypR [***]* 4958 Delavirdine MonitR [***]* 7602 Dengue Virus RNA DetectR/Speciaton Types 1-4 [***]* 1036 Diabetes, Genetic Evaluation [***]* 4957 Didanosine (ddl) MonitR [***]* 1203 DNA Autoantibodies (Crithidia), Double Stranded [***]* 1225 EJ Autoantibodies [***]* 3624C Endotoxin CSF [***]* 3624F Endotoxin Fluid [***]* 3624 Endotoxin Plasma [***]* 2650 Enterovirus RNA DetectR [PCR] [***]* 2651 Enterovirus RNA DetectR reflex to Speciation [***]* 7583 Epstein-Barr Virus DNA Detector [***]* 7584 Epstein-Barr Virus DNA UItraQuant [***]* 7584C Epstein-Barr Virus Dna Ultraquant CSF [***]* 7584PL Epstein-Barr Virus DNA UltraQuant Plasma [***]* 1966 Factor V Mutation (Leiden) [***]* 1440 Fetal Fibronectin by Semi-Quantitative EIA [***]* 12990 Fibroblast Culture [***]* 2655 Flavivirus DetectR Reflex To Speciation [***]* 2654 Flavivirus Rna DetectR [***]* 5362 Fragile X DNA Probe Analysis [SB/PCR] [***]* 5364 Fragile X DNA Probe Analysis With Chromosome Analysis [***]* 4006 Ganglioside GD1a Autoabs [***]* 4041 Ganglioside GD1b Autoabs [***]* 4041C Ganglioside GD1b Autoabs CSF [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PAGE 2 OF 7 3565 Glutathione Peroxidase [***]* 1621 Granulocyte Colon Stimulating Factor [***]* 7506 Hantavirus Hantaan & Puumala IgG & IgM Abs [***]* 7607 Hantavirus Hantaan & Puumala IgG Abs [***]* 7508 Hantavirus Hantaan & Puumala IgM Abs [***]* 7501 Hantavirus Hantaan Igo & 1gM Abs [***]* 7496 Hantavirus Puumala IgG & IgM Abs [***]* 5369 Hemochromatosis DNA GenotypR [***]* 8141 Hepatitis B Virus DNA Detector [***]* 8143 Hepatitis B Virus DNA Quantitation by Branched DNA [***]* 8137 Hepatitis B Virus DNA UltraQuant [***]* 2448 Hepatitis B Virus Surface Ab Quantitation [***]* 2447 Hepatitis C Virus Abs RIBA Confirmation [***]* 2447B Hepatitis C Virus Abs RIBA Confirmation + bands [***]* 7491 Hepatitis C Virus RIBA Evaluation + reflex PCR [***]* 7491B Hepatitis C Virus RIBA Evaluation with reflex PCR [***]* 7486 Hepatitis C Virus RNA AccuQuant [***]* 7476 Hepatitis C Virus RNA AccuQuant reflex GenotypR [***]* 7476SR Hepatitis C Virus RNA AccuQuant rflx GenotypR w/Serial Graph [***]* 7486SR Hepatitis C Virus RNA AccuQuant w/Serial Graphics [***]* 7518 Hepatitis C Virus RNA Detector with reflex Quant [***]* 7516 Hepatitis C Virus RNA DetectR [***]* 7472 Hepatitis C Virus RNA Quantitation by Branched DNA [***]* 7576 Hepatitis C Virus RNA UltraQuant [***]* 7578 Hepatitis C Virus RNA UltraQuant reflex to HCV Genotyper [***]* 7576SR Hepatitis C Virus RNA UItraQuant w/ Serial Graph [***]* 7578SR Hepatitis C Virus RNA UltraQuant w/ Serial Graph reflex to HCV Genotyper [***]* 7473 Hepatitis C Virus SubtypR [***]* 7514 Hepatitis Delta Virus RNA DetectR [***]* 2468 Hepatitis G Virus RNA DetectR [***]* 5842 Her-2/neu [IHC] and Gene Amplification [FISH] [***]* 7581 Herpes Simplex Virus DNA DetectR [***]* 9474 Herpes Simplex Virus DNA UltraQuant [***]* 9474C Herpes Simplex Virus Dna Ultraquant CSF [***]* 9517 Herpes Simplex Virus Encephalitis AccuDx [***]* 7494 Herpesvirus-6 Human DNA DetectR [***]* 7784 Herpesvirus-8, Human Antibodies [***]* 7785 Herpesvirus-8, Human DNA DetectR [***]* 8315UR Histoplasma Antigen In Urine [***]* 7587 Histoplasma DNA DetectR [***]* 3019B HIV-1 IgG Abs W/ Reflex Ib + Bands(Priority) [***]* 3013B HIV-1 Abs Confirmation + bands w/ reflex to HIV-2 + bands [***]* 3012 HIV-1 Abs Confirmation Immunoblot [***]* 3012B HIV-1 Abs Confirmation lmmunoblot + bands [***]* 3012NYB HIV 1 Abs Confirmation Immunoblot + bands, New York [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PAGE 3 OF 7 3012C HIV-1 Abs Confirmation Immunoblot CSF [***]* 3012NY HIV-1 Abs Confirmation Immunoblot, New York [***]* 5721AZT HIV-1 Anti-Viral Drug Study: AZT IC50 Value [***]* 5721DDC HIV-1 Anti-Viral Drug Study: ddC IC50 Value [***]* 5721 DDI HIV-1 Anti-Viral Drug Study: ddl IC50 Value [***]* 5723 HIV-1 Anti Viral Drug Study: Phenotypic Resistance [***]* 5725 HIV-1 Culture, Qualitative [***]* 5727 HIV-1 Culture, Quantitative [***]* 5729 HIV-1 Culture, Quantitative Plasma [***]* 9885NYP HIV-1 DNA Detector New York Prognostic [***]* 9885 H1V-1 DNA DetectR [***]* 9885N HIV-1 DNA DetectR Non-blood [***]* 7479 HIV-1 GenotypR (Protease Inhibitor) [***]* 7479NY HIV-1 GenotypR (Protease Inhibitor) New York [***]* 7477 HIV-1 GenotypR (Reverse Transcriptase Inhibitor) [***]* 7477NY HIV-1 GenotypR (Reverse Transcriptase Inhibitor) New York [***]* 7480 HIV-1 GenotypR PLUS (Rev Trans & Prot Inhib) [***]* 7480NY HIV-1 GenotypR PLUS (Rev Trans & Prot Inhib) New York [***]* 5732 HIV-1 Proviral DNA Accuquant [***]* 9884A HIV-1 RNA Quant by Roche Amplicor [***]* 9884ASR HIV-1 RNA Quant by Roche Amplicor w/ Serial Reporting [***]* 7478NY HIV-1 RNA Quant by Roche reflex HIV GenotypR (RTI) New York [***]* 7482NY HIV-1 RNA Quant by Roche reflex HIV GenotypR PLUS New York [***]* 7483A HIV-1 RNA Quant by Roche reflx Ultrasens + GenotypR (PI) [***]* 7483ASR HIV-1 RNA Quant by Roche reflx Ultrasens+GenotypR PI), Ser R [***]* 9874A HIV-1 RNA Quant by Roche reflx Ultrasensitive [***]* 7482ASR HIV-1 RNA Quant by Roche rflx Ultrasens + Geno R PLUS w/SR [***]* 7478A HIV-1 RNA Quant by Roche rflx Ultrasonsitive+GenotypR (RTI) [***]* 7482NYSR HIV-1 RNA Quant by Roche rfx HIV Geno pR PLUS New York w/SR [***]* 7478NYSR HIV-1 RNA Quant by Roche rfx HIV GenotypR RTI New York w/SR [***]* 7482A HIV-1 RNA Quant by Roche rfx to Ultrasensitive+GenotypR PLUS [***]* 7478ASR HIV-1 RNA Quant by Roche rfx Ultrasens+GenotypR RTI w/SerRep [***]* 7485A HIV-1 RNA Quant by Roche Ultrasensitive [***]* 7485ASR HIV-1 RNA Quant by Roche Ultrasensitive with Serial Graphics [***]* 9874ASR HIV-1 RNA Quant by Roche w/reflx Ultrasensitive w/Serial Rep [***]* 9886 HIV-1 RNA Quantitation by Branched DNA [***]* 9886NY HIV-1 RNA Quantitatian by Branched DNA (New York) [***]* 9884NYP HIV-1 RNA Quantitation New York Prognostic [***]* 9884NYPS HIV-1 RNA Quantitation New York Prognostic w/Serial Report [***]* 9874 HIV-1 RNA UitraQuant [***]* 9872 HIV-1 RNA UItraQuant & CD4 Cell Count [***]* 9872SR HIV-1 RNA UItraQuant & CD4 Cell Count w/Serial Report [***]* 9874NY HIV-1 RNA UItraQuant New York [***]* 9874NYSR HIV-1 RNA UltraQuant New York w/Serial Reporting [***]* 7483SR HIV-1 RNA UItraQuant reflex to HIV GenotypR (PI) w/Ser Re [***]* 7478 HIV-1 RNA UItraQuant reflx to HIV GenotypR ( RTI ) [***]* 7478SR HIV-1 RNA UItraQuant reflx to HIV GenotypR RTI ) w/Ser Rep [***]* 7483 HIV-1 RNA UItraQuant reflx to HlV GenotypR (PI) [***]* 7483NY HIV-1 RNA UItraQuant reflx to HIV GenotypR (Pl) New York [***]*
* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PAGE 4 OF 7
2000 LIST TEST CODE TEST DESCRIPTION PRICE - ------------------------------------------------------------------------------------------------------ 7482 HIV-1 RNA UItraQuant reflx to HIV GenotypR PLUS ( RTI & PI ) [***]* 7482SR HIV-1 RNA UltraQuant reflx to HIV GenotypR PLUS w/Serial Rep [***]* 7483NYSR HIV-1 RNA UltraQuant rfx HIV GenotypR (PI) New York w/Serial [***]* 9874SR HIV-1 RNA UItraQuant with Serial Reporting [***]* 9915 HIV-1/HIV-2 Antibodies Plus Confirmation [***]* 9915NY HIV-1/HIV-2 Antibodies Plus Confirmation New York [***]* 9915B HIV-1/HIV-2 Antibodies Plus Confirmation W/Bands [***]* 9915NYB HIV-1/HIV-2 Antibodies Plus Confirmation W/Bands New York [***]* 9876NY HIV-2 DNA Detector Qual New York [***]* 9876 HIV-2 DNA DetectR [***]* 1364 HLA B27 GenotypR [***]* 1351 HLA: A, B, & C Typing, Complete [***]* 1035 HLA: A, B, C, & D Typing, Complete [***]* 1357 HLA: DR Single Antigen [***]* 1352 HLA: DR Typing, Complete [***]* 1706 HLA: DR2 & DQI - Narcolepsy Evaluation [***]* 1353 HLA: DR3 - Celiac Disease [***]* 9896 HTLV-I / II DNA DetectR [***]* 1820 Human Papillomavirus DetectR [***]* 1824 Human Papillomavirus DetectR reflx to GenotypR [***]* 1822 Human Papillomavirus GenotypR [***]* 1882 lmmunoglobulin Gene Rearrangement, Heavy -chain JH probe [***]* 1884 Immunoglobulin Gene Rearrangement, Kappa Light-chain Probe [***]* 4965 Indinavir MonitR [***]* 2594 Influenza A & B MultiplexR [***]* 3868 Interleukin-1 beta [***]* 3868C Interleukin-1 beta CSF [***]* 3816 Interleukin-1 RA [***]* 3823 Interleukin-10 [***]* 3812 Interleukin-12 [***]* 3870 Interleukin-2 [***]* 3870C Interleukin-2 CSF [***]* 3832C lnterleukin-2 Receptor CSF [***]* 3832 Interleukin-2 Receptor, Soluble [***]* 3832SF Interleukin-2 Receptor, Soluble Synovial Fluid [***]* 3814 lnterleukin-4 [***]* 3827 Interleukin-5 [***]* 3828 Interleukin-6 [***]* 3822 Interleukin-8 [***]* 3822BW Interleukin-8 Bronchial Wash [***]* 3535 Iron Status MonitR [***]* 8145 JC Virus DNA DetectR [***]* 8147 JC Virus Ultraquant [***]* 8147C JC Virus Ultraquant CSF [***]* 1222 Ku Autoantibodies [***]* 4966 Lamivudine (3TC) MonitR [***]* 4861W Lead Whole Blood [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PAGE 5 OF 7 4861NY Lead Whole Blood New York [***]* 2920 Legionella pneumophila DNA DetectR [***]* 1670 Leukemia / Lymphoma Blood Evaluation [***]* 1672 Leukemia / Lymphoma Blood Reflexive Evaluation [***]* 1667 Leukemia / Lymphoma Bone Marrow Evaluation [***]* 1674 Leukemia / Lymphoma Evaluation Blood [***]* 1679 Leukemia / Lymphoma Evaluation Bone Marrow or Tissue [***]* 1682 Leukemia / Lymphoma Panel, Chronic Bone Marrow or Tissue [***]* 1666 Leukemia / Lymphoma Tissue or Body Fluid Evaluation [***]* 1676 Leukemia / Lymphoma, Comprehensive Blood [***]* 1677 Leukemia / Lymphoma, Comprehensive Bone Marrow or Tissue [***]* 3978 Leukocyte Alkaline Phosphatase Stain [***]* 1062 Lymphocyte Antigen & Mitogen Proliferation Analysis [***]* 1648 Lymphocyte Antigen Proliferation Analysis [***]* 1641 Lymphocyte Mitogen Proliferation Analysis, PWM [***]* 1661 Lymphoma Panel [***]* 8370 Malaria DNA DetectR [***]* 4995 Megaloblastic Anemia EvaluatR [***]* 4559 MTHFR A1298C Mutation [***]* 9728 Mumps RNA DetectR [***]* 7475 Mycobacterium Tuberculosis DNA PCR [***]* 7470 Mycobacterium Tuberculosis GenotypR [***]* 2929 Mycoplasma MultiplexR [***]* 2924 Mycoplasma pneumoniae DNA DetectR [***]* 2930 Neisseria gonorrhoeae Detection rRNA [***]* 2932 Neisseria gonorrhoeae DNA LCR [***]* 4951 Nelfinavir MonitR [***]* 4954 Nevirapine MonitR [***]* 4556 Obstetric Complications AssessR [***]* 1223 OJ Autoantibodies [***]* 1559 Oligodonal Immunoglobulins [AE] [***]* 7452 Osteoporosis EvaluatR [***]* 7447 Osteoporosis Monitor [***]* 2367 Ova & Parasite: Arthropod Identification [***]* 2363 Ova & Parasite: Coccidia Evaluation [***]* 2362 Ova & Parasite: Comprehensive Exam w/ Coccidia Evaluation [***]* 2361 Ova & Parasite: Routine Exam [***]* 2368 Ova & Parasite: Worm Identification [***]* 3872 Pancreatitis DetectR [***]* 3872UR Pancreatitis DetectR, Urine Random [***]* 8266 Parvovirus B19 DNA DetectR [***]* 8260 Parvovirus B19 DNA UltraQuant [***]* 8261 Parvovirus B19 Evaluation [***]* 8261C Parvovirus B19 Evaluation CSF [***]* 1224 PL-12 Autoantibodies [***]* 1226 PL-7 Autoantibodies [***]* 5372 Prothrombin G20210A Mutation [***]* * PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PAGE 6 OF 7 7522 Respiratory Synctyial Virus RNA DetectR [***]* 4952 Ritonavir MonitR [***]* 4967 Saquinavir MonitR [***]* 4031 Sensory Neuropathy Evaluation [***]* 4030 Sensory Neuropathy EvaluatR [***]* 3254 Small-cell Carcinoma Monitor, Lung [***]* 3222 Somatostatin [***]* 1227 SRP Autoantibodies [***]* 2934 Staph Resist MultipleXR [***]* 4953 Stavudine (d4T) MonitR [***]* 1880 T-cell Receptor Gene Rearrangement [***]* 1634 Terminal Deoxynucleotidyl Transferase Bone Marrow or Tissue [***]* 1635 Terminal Deoxynucleotidyl Transferase with Immunophenotyping [***]* 5985 Thrombus Precursor Prot [***]* 7521 Toxoplasma DNA DetectR [***]* 8972 Toxoplasma Encephalitis AccuDx [***]* 4002 Transferrin Genetic D Variants [***]* 7573 Tropheryma whippelii DNA DetectR [***]* 3390 Troponin (I & T) DetectR [***]* 3393 Troponin I [***]* 3294BW Tumor Necrosis Factor-alpha Bronchial Wash [***]* 3294C Tumor Necrosis Factor-alpha CSF [***]* 3294 Tumor Necrosis Factor-alpha Plasma [***]* 3908 Tumor Necrosis Factor-binding Proteins [***]* 3908C Tumor Necrosis Factor-binding Proteins CSF [***]* 1228 U2 SnRNP Autoantibodies [***]* 1662 Undifferentiated Tumor Panel [***]* 5200 Urinalysis [***]* 7439 Ur-Sure Chlamydia trachomatis/Neisseria gonorrhoea bLCR [***]* 7585 Varicella-zoeter Virus DNA DetectR [***]* 8760 Varicella-Zoster Virus DNA Ultraquant [***]* 8760C Varicella-Zoster Virus Dna Ultraquant CSF [***]* 5975 Venous Thromboembolism (VTE) AssessR [***]* 2442 Viral Diarrhea Ag Detection [***]* 9530 Viral Encephalitis DetectR [***]* 4958 Zalcitabine (DDC) MonitR [***]* 4959 Zidovudine (AZT) MonitR [***]*
* PORTIONS OF THIS PAGE HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. PAGE 7 OF 7 ATTACHMENT D SPECIALTY LABORATORIES January 27, 1999 J.P.C. Praful Shah Director of Laboratory Services 1865 Broadway New York, NY 10023 RE: Request for Proposal Dear Mr. Shah Thank you for inviting Specialty Laboratories to resubmit an addendum proposal to J.P.C.. Please find enclosed a revised proposal for your review, including a detailed list of the pricing for our state-of-the-art testing. SPECIALTY is offering an aggressive pricing schedule to J.P.C.. As you review our proposal, please keep in mind the qualities that differentiate SPECIALTY: - - SPECIALTY'S test menu is designed to complement rather than compete with a hospital's offering. We are the only full-service esoteric laboratory that does not compete for routine tests such as CBC's, chemistry, routine toxicology, routine cytology/histology, etc. - - SPECIALTY has an outstanding Information Technology program with the DataPassport-TM- suite of linkage options designed to meet the individual needs of each facility and to serve the requirements of hospital networks as well. - - Specialty Laboratories is dedicated to a continuous research and development - employing more than 30 M.D. and Ph.D. level scientists to develop new test methodologies, review clinical data and assess testing needs to meet disease trends. - - Members of our clinical and technical staff are available to answer your results inquiries and explain test performance parameters. We also have round-the-clock Client Services coverage. - - We accept specimens and perform procedures 7 days per week, 24 hours a day with most high volume assays set up daily and, in many instances, in multiple runs. This may be of particular interest when considering live-cell specimens. - - SPECIALTY'S commitment to quality is second to none. J.P.C. and its associated facilities will enjoy the very best in reference laboratory testing. SPECIALTY is CAP, CLIA and CDC certified and also participates in a large number of additional quality assurance and proficiency programs. We are especially proud that Specialty Laboratories is the reference laboratory of choice for hundreds of hospitals and medical centers throughout the nation and would welcome the opportunity to serve J.P.C.. If you have any questions regarding this proposal, please feel free to call me at ###-###-#### or Kevin Pishkar at ext. 637. We look forward to establishing a successful long-term relationship with J.P.C. and its associated facilities. Sincerely, /s/ Gary W. Nay Gary W. Nay Supervisor - Contract Administration Enclosures cc: Kevin Pishkar